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ABSTRACT
Substance use disorders are a widespread issue in society today with 
approximately 20 million people in the U.S. alone experiencing drug-related problems 
(Substance Abuse and Mental Health Services Administration, 2012). However, 
treatment is often ineffectual with approximately 50% o f addicted individuals returning 
to substance use. One factor found to impact individuals’ treatment response is their 
neuropsychological functioning. Drug-abusers frequently exhibit severe executive 
functioning impairments across a number o f  domains, and there is evidence that these 
deficits may be time and substance-dependent. Executive functions are mental processes 
critical in motivation, planning, and goal-directed behaviors. With extended abstinence, 
research suggests cognitive improvements will occur for many addicts.
The goal o f  the present study was to evaluate specific impairments in cognitive 
abilities and executive functions associated with substance abuse for individuals entering 
residential treatment and to assess the relationship between self-report executive 
functioning problems and functioning observed on neuropsychological tests. It was 
hypothesized that participants would exhibit significant impairments in the areas o f 
working memory, set-shifting, inhibition, planning, verbal fluency, and sustained 
attention. Further, it was hypothesized that improvements in executive functioning would 
be observed after approximately 45 days o f  treatment. Moreover, it was hypothesized that 
executive functioning measures, both self-report and performance-based, would predict
substance-related problems, years o f  abuse, and problematic personality traits. Finally, 
better neurocognitive functioning at intake was hypothesized to be related to treatment 
retention.
This study examined adult participants receiving treatment within a private 
residential addiction center. Findings generally did not provide support for hypotheses. 
Results found participants reported significant levels o f  executive functioning problems 
but exhibited significantly poorer performance on only one neuropsychological measure 
(Comprehensive Trail-M aking Task) compared to established norms which indicated 
deficits in set-shifting ability. Further, significant improvements at follow-up testing were 
observed in only three executive functioning tasks, although fewer executive functioning 
problems were reported by participants across multiple domains. It may be that more 
extensive cognitive improvements were not observed given the generally average 
performance o f  the sample across the neuropsychological battery administered. Further, 
the only executive functioning measure found to be a significant predictor o f substance- 
related problems and problematic personality traits was the self-report Barkley Deficits in 
Executive Functioning Scales. Finally, scores on initial executive functioning measures 
were not found to be predictive o f treatment retention. One possible explanation for these 
results may be the characteristics o f  the sample studied as the participants were generally 
well-educated with likely higher levels o f  general cognitive functioning compared to 
similar research.
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Substance abuse is one o f  the most prevalent psychiatric and social problems 
within the United States today. Between 2002 and 2011, the estimated annual number o f 
people exhibiting substance abuse or dependence ranged from 20.6 million to 22.7 
million. In 2011, approximately 8% o f  the population aged 12 or older (20.6 million 
people) experienced a substance use disorder while only 3.8 million people received any 
type o f  treatment (Substance Abuse and Mental Health Services Administration, 2012). 
Unfortunately addiction treatment often is unsuccessful with 40%-60% o f addicted 
individuals relapsing (National Institute on Drug Abuse, 2012). One factor which may be 
especially integral in individuals’ response to treatment is their cognitive functioning. 
Deficits in executive cognitive functioning have been exhibited by both substance- 
abusing individuals and former substance abusers who are currently abstinent. The 
pattern o f  deficits displayed are likely to be influenced by an individual’s primary drug o f 
choice, length o f usage, and level o f  exposure. For example, alcohol-dependent 
individuals exhibit significant impairments in executive functions and visual-spatial 
ability. Interestingly, however, fewer problems and less impairment are found in general 
intelligence, declarative memory, and language skills compared to healthy controls 
(Crews et al., 2005). Further, specific cognitive impairments in working memory and 
attentional abilities have been associated with length o f  abuse in alcohol-dependent
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patients with increasing duration o f  dependence relating to more severe cognitive deficits 
(Loeber et al., 2009). Importantly, there is substantial evidence to suggest that some 
cognitive abilities and executive functioning (EF) will improve after a period o f sobriety 
regardless o f the drugs administered and abused.
Additionally, the influence o f  cognitive dysfunction in the treatment process has 
been examined in a limited fashion, and deficits have been found to be associated with 
reduced retention, client engagement, and motivation for treatment (Blume, Schmaling,
& Marlatt, 2005; Katz et al., 2005; Verdejo-Garcia et al., 2012). Further, Blume and 
Marlatt (2009) concluded that certain impairments, especially in decision-making, 
problem-solving, and memory, are likely to prevent some individuals from productively 
participating in treatment. Notably, neuropsychological assessments appear to be 
particularly critical given the fact that counselors have been found to be unable to reliably 
identity clients with cognitive impairments (Fals-Stewart, 1997).
The goal o f  the present study was to further evaluate specific cognitive 
impairments o f  a sample o f  substance abusers, as well as investigating longitudinal 
changes in executive cognitive functions exhibited by a unique population o f  individuals 
undergoing residential addiction treatment. In addition, this study examined the 
relationship between EF and response to substance abuse treatment.
Review o f the Literature 
Executive Functioning
Executive functioning is a complex construct, or metaconstruct, referring to a 
broad set o f  mental processes responsible for several goal-directed behaviors, such as 
planning, self-monitoring, and self-regulating (Goldberg, 2002). These future-oriented
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processes have been described as “a self-directed set o f  actions intended to alter a delayed 
(future) outcome” (Barkley, 2011, p. 11). EF is believed to be critical in higher-order 
cognitive processes and involves inputs from multiple cognitive domains, such as 
language, memory, and perception (Duke & Kaszniak, 2000). EF is also believed to be 
involved in self-evaluations, such as individuals’ metamemory judgm ents (Mantyla, 
Ronnlund, & Kliegel, 2010). These supervisory capabilities are generally considered to 
be produced within the frontal lobes o f the human brain and are involved in both 
neurological activity and behavioral manifestations (Goldberg, 2009).
Lezak (1995) differentiates executive functions from cognitive functions, 
explaining that EF skills address questions o f how and whether an individual performs a 
particular action. In contrast, cognitive functions are related in terms o f what or how 
much o f some specific ability one possesses or exhibits. Importantly, an individual could 
remain productive and independent in the presence o f  significant cognitive loss if  EF 
abilities remains intact (Lezak, 1995).
The cognitive and neural processes which are believed to underlie executive 
functions start to develop in infancy. However, there is some debate over whether the 
development o f  EF skills is continuous from early preschool to later preschool years or if  
these skills differentiate later in the developmental process (Mandell & Ward, 2011). 
These researchers, in a study utilizing Macaca fascicularis monkeys during infancy and 
the early juvenile period, found that two independent cognitive skills appear to be 
especially important in EF development. The modulation o f response to novel stimuli and 
the ability to persist and maintain an appropriate response set while experiencing negative
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feedback are likely to be critical early skills contributing to other EF abilities (Mandell & 
Ward, 2011).
Furthermore, Clark, Pritchard, and Woodward (2010) found that measures o f EF 
(inhibition, set shifting, and general executive behavior measures) at age four were 
predictive o f children's math achievement in school two years later. These functions 
continue to develop throughout childhood and adolescence as related brain areas undergo 
significant changes. For example, the dorsal lateral prefrontal cortex may be one o f  the 
last brain regions to fully develop and it is believed to be associated with impulse control 
(Giedd, 2004). Researchers have estimated that full maturation o f the prefrontal cortex 
likely does not occur until adults reach their 20s, according to magnetic resonance 
imaging (MRI) research (Giedd, 2004).
Contemporary research appears to support the notion that there exists no unitary 
executive function, but instead several diverse functions (Miyake et al., 2000; Stuss & 
Alexander, 2000). Currently, there is no consensus among researchers on what specific 
neural and behavioral functions compose the broad term executive functioning (Alvarez 
& Emory, 2006). However, in spite o f  there being no complete understanding o f these 
abilities, there are several components which are frequently incorporated into 
conceptualizations o f  EF, such as cognitive flexibility, working memory, inhibition, 
planning, decision-making, and attention.
Models o f Executive Functioning
There are various theories and conceptualizations aimed at organizing and 
describing the “supervisory” cognitive functions that comprise executive functioning 
(Alvarez & Emory, 2006). The meta-analysis o f Alvarez and Emory (2006) describes
5
how factor-analytic studies and empirical and theoretical research have somewhat 
differed when describing the component processes o f EF, resulting in the creation o f 
many interrelated constructs such as cognitive flexibility, problem-solving, response 
maintenance, working memory, inhibition and switching, and sustained attention. In 
addition, Hofmann, Schmeichel, and Baddeley (2012) describe the basic elements o f  EF 
as subserving the overall process o f self-regulation.
One o f  the original models o f EF was proposed by Baddeley (1996) who 
postulated a model o f  working memory which includes three components: visuospatial 
sketchpad, phonological loop, and central executive. Visual and spatial information is 
organized by the visuospatial sketchpad while phonological information is controlled by 
the phonological loop. The central executive is formulated and depicted as the central 
control structure through which other cognitive processes and behaviors are regulated and 
controlled.
Another model was proposed by Lezak (1995) who states that EF is made up o f 
four main components: volition, planning, purposive action, and effective performance. 
Volition is defined as the ability to consider one’s future needs and having sufficient 
motivation to formulate an intention to accomplish goals. Planning involves considering 
available options and breaking down goals into progressive steps. Purposive action 
involves programming activities in order to control behaviors, especially those that are 
nonroutine. Finally, effective performance depends on how well one monitors and 
regulates ongoing behaviors (Lezak, 1995).
Additionally, Barkley (2001) argues against a purely information-processing 
conceptualization o f executive functions as he applies an evolutionary framework to his
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model o f  EF. He defines EF as “self-regulation across time for the attainment o f future 
goals” (Barkley, 2011, p. 79). He argues that these functions are forms o f behavior-to- 
the-self that evolved to be private responses as a means o f self-regulation. The proposed 
functions are “private, covert forms o f behavior that at one time in early child 
development (and in human evolution) were entirely publicly observable” (Barkley,
2001, p. 7). This biological adaptation was necessary because o f interpersonal 
competition within group-living species, and these functions shift the behavioral control 
from the immediate social context to self-regulation which utilizes internal 
representations concerning one’s possible social future. Furthermore, executive functions 
evolved in order to solve certain adaptive problems, such as social exchange and 
vicarious learning (Barkley, 2001).
Barkley (2001) explains that response inhibition is the initial function which 
allows for the four other processes to occur. Nonverbal working memory involves 
sensory-motor actions and has both retrospective and prospective elements. Private 
mental representations are produced by this process. This function is sensing to the self, 
both covert seeing and hearing. Verbal working memory involves the internalization o f 
speech as the related cortical areas are activated without the physical manifestation o f 
speech. This function is known as covert self-directed speech. Covert self-directed 
emotion involves the self-regulation o f  affect, motivation, and arousal through the 
manipulation o f  the first two functions. Barkley (2001) claims that this function is the 
foundation o f intrinsic motivation. Finally, covert self-directed play, reconstitution, is the 
process o f  generating novel goal-oriented actions through the analysis and synthesis o f
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old behavioral units into effective adaptations. This function is analogous to flexibility or 
fluency (Barkley, 2001).
Recent conceptualizations focus on a three-factor model with the following 
commonly described aspects o f EF; set-shifting, monitoring or updating o f  working 
memory, and response inhibition (Diamond, 2013; Miyake et al., 2000). Additionally, 
Verdejo-G arda and Perez-Garcia (2007), based on principal component analysis, argue 
that there is a fourth independent component o f  EF beyond these three, decision-making, 
which is defined as the ability to choose the most adaptive course from a set o f possible 
behaviors. Attention has also been directed to the skills o f  planning and problem-solving 
which are believed to be critical elements o f EF (Barkley, 2011).
Set-Shifting. Using a latent variable approach, Miyake et al. (2000) examined the 
underlying differences between the set-shifting, updating o f working memory, and 
inhibition constructs. Set-shifting (also known as cognitive flexibility) is described as the 
ability to shift between mental sets. This involves switching attention and disengaging 
from one task in order to engage in a more relevant task set. Additionally, another 
explanation o f  this construct is the ability to perform a task despite the effects o f 
proactive interference (Miyake et al., 2000).
Anatomically, W ilmsmeier et al. (2010), using functional magnetic resonance 
imaging (fMRI), found activation in the bilateral dorsolateral prefrontal cortex 
(Brodmann’s area 46) to be associated with behaviors performed during set-shifting 
tasks. There is also evidence that the neural activation associated with shifting amongst 
mental sets is different for individuals with certain psychiatric disorders, such as 
schizophrenia (W ilmsmeier et al., 2010). Further, Diamond (2013) explained that set-
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shifting develops later in individuals and builds upon working memory and response 
inhibition in problem-solving.
Goldberg (2009) refers to this construct as cognitive flexibility through which 
both stability and plasticity are exhibited. Cognitive plasticity refers to the ability to shift 
cognitive sets in response to environmental stimuli while cognitive stability refers to 
one’s ability to use internal representations to guide behavior. Goldberg (2009) reports 
that damage to the frontal lobe can lead to two types o f deficits in behavior within these 
domains, perseverance and field-dependent behavior. Perseverance is a lack o f  plasticity 
as one cannot fully switch between mental tasks. Field-dependent behavior refers to the 
inability to sufficiently stay on task and complete an objective. Goldberg (2009) also 
describes the term “dynamic bystability” as the ability to both effectively attend to 
stimuli and successfully shift to new tasks when necessary, without interference from 
previous sets.
Monitoring or Updating o f W orking Memory. Updating o f  working memory 
representations, also known as monitoring, is believed to be another critical executive 
function. This function involves several important cognitive skills including monitoring 
and coding information being held in working memory, while simultaneously 
manipulating this information in beneficial ways in order to aid in problem-solving needs 
(Miyake et al., 2000). Other skills are considered to be associated with the function o f 
working memory, such as fluency and reasoning ability which have been found to 
contribute to the updating component (Verdejo-Garcia & Perez-Garcia, 2007). Updating 
o f working memory has also been found to be related to an individual’s level o f  effortful 
control (Bridgett, Oddi, Laake, Murdock, & Bachmann, 2013). Working memory tasks
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are often utilized to measure this ability which has been associated with the dorsolateral 
portion o f  the prefrontal cortex (Miyake et al., 2000).
Response Inhibition. An additional major executive function frequently 
proposed is response inhibition (or inhibitory control). This ability involves the inhibition 
o f prepotent responses. This is the active and intentional suppression o f  automatic or 
dominant responses to stimuli. According to Barkley (2001), the term response inhibition 
has also been used to refer to two other distinct processes. It has also been used to 
describe the cognitive processes o f sensitivity to error and interference control/resistance 
to distraction. Sensitivity to error refers to the ability to interrupt an ongoing, ineffective 
response in order to create delay in the decision to continue this response, while 
interference control is related to the ability to protect self-directed cognitive responses 
and goal-directed behaviors from extraneous stimuli (Barkley, 2001).
This function is often measured using the Stroop Color-Word Test (Miyake et al., 
2000). Further, two o f the most commonly used types o f  tasks for measuring response 
inhibition are the go/no-go paradigm and the stop-signal task (Criaud & Boulinguez, 
2013). Several brain regions are activated during a go/no-go task administration (Swick, 
Ashley, & Turken, 2011), including multiple areas o f  the lateral frontal cortex such as the 
“superior, middle and inferior frontal gyri), the insula, the dorsal medial frontal cortex 
(including the supplementary and pre-supplementary motor areas), the anterior cingulate 
cortex, the inferior parietal cortex, the precuneus, as well as the striatum” (Criaud & 
Boulinguez, 2013, pp. 12). However, these researchers go on to explain that not all o f 
these brain areas are directly related to the neural inhibition processes. In their review o f 
fMRI studies, Criaud and Boulinguez (2013) conclude that a portion o f the neural activity
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observed during go/no-go tasks may be related to other executive functions, such as the 
engagement o f  working memory resources.
Planning Ability and Problem-Solving. The neurocognitive processes o f 
planning and problem-solving have also been characterized as elements o f executive 
functioning by some researchers (Barkley, 2011), while others have conceptualized these 
abilities as higher-order skills directly related to executive functions. Planning ability 
involves the capacity to map out the strategies needed to attain an identified goal and 
subsequently generate the cross-temporal behavioral structures necessary. Problem­
solving ability involves both the construction o f an initial plan for goal-directed behaviors 
as well as the generation o f  possible alternative options should goal-directed actions be 
found to be unsuccessful.
Planning and problem-solving have been found to be associated with, and 
influenced by, several other cognitive processes, including the three primary executive 
functions (set-shifting, working memory, and response inhibition). For example, fluid 
reasoning, which involves abstract reasoning, likely has a strong effect on problem­
solving skills (Unterrainer et al., 2004). Further, problem-solving is believed to involve 
the utilization o f  the working memory function (Barkley, 2011) with the influence o f  the 
updating ability increasing as the difficulty o f a problem-solving task increases (Miyake 
et al., 2000). In addition, research suggests that planning time may influence problem­
solving ability. Increased preplanning time has been found to be related to scores on 
problem-solving tasks (Unterrainer et al., 2004). There is also evidence that supports a 
significant positive relationship between response inhibition and problem-solving (Zook, 
Davalos, DeLosh, & Davis, 2004). Finally, there appears to be mixed findings in regards
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to the relation between set-shifting and problem-solving, with Zook et al. (2004) finding 
no association between these two processes. In contrast, Bugg, Zook, DeLosh, Davalos, 
and Davis (2006) found a significant positive relationship between shifting and problem­
solving abilities, as measured by performance on the Tower o f  London task.
Sustained Attention. In addition to these executive functions, there are other 
related cognitive abilities which greatly impact everyday functioning. One o f these 
abilities is sustained attention, also known as vigilant attention, which involves the 
capacity to maintain attention to specific stimuli, especially in monotonous and 
uninteresting situations. Evidence suggests that in intellectually unchallenging activities it 
is often more difficult for individuals to maintain continuous attention as compared to 
more interesting, variable, and cognitively demanding tasks (Langner & Eickhoff, 2013). 
Sarter, Givens, and Bruno (2001) explain that sustained attention is a fundamental aspect 
o f  attention which indicates one’s ability to detect infrequent stimuli over an extended 
period o f  time and is associated with activity within the frontal and parietal cortices. In 
their meta-analysis, Langner and Eickhoff (2013) report that multiple neural regions are 
associated with sustained attention, including areas o f  the prefrontal cortex, parietal lobe, 
and subcortical structures. Further, Yu (2011) proposes a relationship between the 
process o f  sustained attention and the function o f  the neuromodulator acetylcholine. An 
individual’s level o f  sustained attention is often measured by vigilance tasks. Moreover, 
sustained attention has been theorized to be one o f  four types o f  attention, including 
shifting attention, divided attention, and focused attention (Lezak, Howieson, & Loring, 
2004).
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Another related cognitive process which has garnered extensive research is 
decision-making. This ability has been argued to be an independent component o f  EF by 
some researchers (Verdejo-Garcia & Perez-Garcia, 2007). One model to explain this 
ability, developed by Damasio, Tranel, and Damasio (1991), is aimed at describing the 
interaction between emotion and decision-making. The Somatic Marker Hypothesis 
(SMH) proposes that the somatic states experienced during learning are pivotal in an 
individual’s ability to appropriately respond to previously perceived stimuli. These 
markers are bodily states which help one identify the value o f possible options and allow 
for decision-making to be a somewhat automated function. However, some researchers 
have questioned the accuracy and extensiveness o f  this hypothesis. Colombetti (2008) 
claims that the SMH contains at least two independent hypotheses. The SMH-G states are 
needed in decision-making and implement preferences in particular situations. Further, 
the SMH-S proposes that these somatic markers are also needed to consider possible 
long-term consequences o f  potential options (Colombetti, 2008).
There are several additional executive functions which have been formulated and 
researched, such as self-motivation, verbal fluency, reward processing, and judgment 
(Barkley, 2011; Golub, Starks, Kowalczyk, Thompson, & Parsons, 2012; Manning et al., 
2008). Importantly, all o f  the primary EF abilities discussed have been studied in terms o f 
their relationships with substance use and dependence.
Executive Functioning and the
Human Brain
Research and assessment o f  executive functioning has historically focused on 
relating observed behaviors (performance on tasks) with neural activity and brain 
structures. For example, performance on the W isconsin Card Sorting Test is believed to
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be related to activity in the lateral prefrontal and parietal cortices. Additionally, thicker 
cortex in these identified areas is associated with scores on this measurement tool 
(Burzynska et al., 2012). Further, several EF tasks have been specifically designed to 
identify particular types o f  brain damage, such as the Iowa Gambling Task (IGT) which 
was originally designed to be a measure o f  decision-making in order to identify 
individuals with ventromedial prefrontal cortex damage (Bechara, Damasio, Damasio, & 
Anderson, 1994).
Overall, many researchers have postulated that executive functions o f the human 
brain are located in the prefrontal cortex o f  the frontal lobe which is interconnected to all 
major areas o f the brain (Goldberg, 2009). However, there exists significant debate over 
the nature o f the connection between executive functions and frontal lobe regions, 
specifically whether particular neural areas correspond with specific observable 
functions.
Alvarez and Emory (2006) reported that there may not be a one-to-one 
correspondence between frontal lobe activity and specific executive functions. In their 
meta-analysis, these researchers found that commonly used neuropsychological measures 
(Wisconsin Card Sorting Test, Stroop Color-W ord Interference Test, and Phonemic 
Verbal Fluency) did not exhibit specificity in measuring frontal lobe functioning. Further, 
Stuss and Alexander (2000) explain that one major problem in research in EF is the fact 
that there is inconsistence in the use o f  both anatomical and psychological definitions. 
Alvarez and Emory (2006) conclude that there should be an emphasis on the 
measurement o f observable behaviors in relation to executive functions.
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Despite these concerns about the efforts to connect psychological constructs to 
anatomical structures, the relationship between specific cognitive functions and particular 
brain areas is often examined by studying individuals who have suffered frontal lobe 
damage. For example, deficits in planning ability and problem-solving abilities (as 
measured by the Tower o f  London task) have been found to be associated with lesions in 
the left anterior frontal lobe (Shallice, 1982). Further, specific brain structures have been 
found to be related to certain cognitive processes, as the anterior cingulate cortex is 
considered to be critical for the process o f selective attention (Alvarez & Emory, 2006).
Additionally, multiple researchers have focused on three main frontal-subcortical 
circuits (dorsolateral, ventromedial and orbitofrontal) being involved in several cognitive 
and motivational processes (Alvarez & Emory, 2006). The dorsolateral frontal cortex has 
been linked to multiple executive functions, such as set-shifting, planning, and working 
memory (Duke & Kaszniak, 2000). Damage to the orbitofrontal cortex has been found to 
be related to socially inappropriate behaviors, impulsivity, and disinhibition. The 
ventromedial circuit is believed to be involved in motivation, and lesions in this area are 
associated with apathy and social withdrawal (Alvarez & Emory, 2006).
Impairments in Executive Functioning
Impairment in EF can lead to significant and global problems across a wide range 
o f  behavioral domains which often can be recognized by both experts and casual 
observers. Deficits can lead one to be unable to perform satisfactory self-care, as well as 
being unable to work independently in an effective manner (Lezak, 1995). An 
individual’s ability to exhibit appropriate social behaviors and maintain normal 
interpersonal relationships also can be greatly diminished by reductions in EF. Some o f
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the behavioral indications o f impairment include emotional lability, flattened affect, 
irritability, rigidity, impulsivity, decreased grooming and cleanliness, and problems 
shifting attention, as well as a general decline in self-control and self-direction (Lezak, 
1995).
EF abilities, and impairments, have also been found to be associated with specific 
personality characteristics, psychiatric disorders, and behavioral problems, such as 
aggression, depression, and certain personality disorders, for both adolescents and adults 
(Dunkin et al., 2000; Holler & Kavanaugh, 2012; Murdock, Oddi, & Bridgett, 2013; 
Santor, Ingram, & Kusumakar, 2003; V erdejo-Garda, Lopez-Torrecillas, Gimenez, & 
Perez-Garcia, 2004). Interestingly, EF skills have also been found to be related to 
religiosity and predictive o f postconventional moral reasoning abilities (Cottone,
Drucker, & Javier, 2007).
Openness to experience and neuroticism have been found to be significantly 
correlated with measures o f  EF, as well as intelligence and fluency (Murdock, et al.,
2013; Schretlen, van der Hulst, Pearlson, & Gordon, 2010). In a study examining the 
relationship between the Big Five personality traits and elements o f EF, Murdock et al. 
(2013) found that lower neuroticism was related to increased updating/monitoring 
abilities, as was higher levels o f openness to experience. Openness was further found to 
be positively associated with measures o f  cognitive flexibility. Moreover, higher levels o f 
expressed negative affect appear related to lower response inhibition abilities (Bridgett, et 
al., 2013). Other researchers have found neuroticism to be negatively correlated with 
fluency and EF (as measured by the Wisconsin Card Sorting Test) while openness was 
positively related to these abilities. However, these researchers also found that
16
verbal/crystallized intelligence was more strongly associated neuroticism and openness 
when compared to EF and fluency (Schretlen, et al., 2010).
Individuals with obsessive compulsive personality traits exhibit decreased 
performance on objective measures o f  EF, Spatial Working Memory tasks, ID/ED tasks, 
and the Stockings o f  Cambridge task, and report significantly more impairment in 
abilities when compared to a sample o f  normal controls (Garcia-Villamisar & Dattilo, 
2015). Similarly, individuals with borderline personality disorder exhibit significant 
deficits in cognitive planning, sustained attention, and working memory when compared 
to controls (Gvirts et al., 2012). Interestingly, self-harming, borderline-disordered 
individuals exhibit higher scores on non-planning impulsivity measures when compared 
with those borderline participants who do not engage in self-harming behaviors.
However, these groups do not exhibit significant differences in objective measures o f 
executive functions (Claes, Van den Eynde, Guillaume, Vogels, & Audenaert, 2012)
Further, aggression and EF likely share some o f the same neural correlates. EF 
has been found to be a moderator between physical aggression and emotional distress 
(Sprague, Verona, Kalkhoff, & Kilmer, 2011). Head injury, decreased verbal intelligence, 
and EF have been found to be related to higher levels o f  intimate partner aggression in a 
sample o f male perpetrators (Walling, Meehan, Marshall, Holtzworth-Munroe, & Taft, 
2 0 1 2 ).
Executive functioning-impaired individuals’ difficulties in problem-solving are 
likely to lead to increased levels o f aggression (Hancock, Tapscott, & Hoaken, 2010). 
Specifically, decreased impulse control was related to acts o f aggression in one adult 
sample analyzed (Stanford, Greve, & Gerstle, 1997). Additionally, in an adolescent
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sample, response inhibition and interference control were found to be negatively related 
to disruptive behavior disorders. Within the same adolescent sample, planning ability and 
problem-solving were found to be negatively associated with anxiety disorders (Holler & 
Kavanaugh, 2012). Further, self-report executive functions have been found to be 
predictive o f  intoxicated aggression in a sample o f healthy social drinkers (Giancola, 
Godlaski, & Roth, 2012). Overall, executive functions are believed to be related to one’s 
ability to inhibit expressions o f  aggression.
Cognitive deficits, such as impairments in EF, are also associated with major 
depressive disorder. Specifically, many individuals suffering from depression exhibit 
deficits consistent with dysfunctions within frontal-subcortical regions (Dunkin et al., 
2000). In a meta-analysis aggregating 113 studies, Snyder (2013) found significant 
deficits in shifting, verbal working memory, inhibition, planning, and updating, as well as 
other executive functions, in individuals experiencing major depressive disorder. Further, 
individuals experiencing subclinical dysphoria may also be more likely to exhibit 
impairments on objective neuropsychological measures.
Interestingly, the long-term usage o f  antidepressant medications may be 
associated with increased impairment for individuals suffering from depression (Snyder, 
2013). Additionally, individuals with major depression who also exhibit prefrontal 
dysfunction are more likely to have poorer responses to certain antidepressant 
medications (Dunkin et al., 2000). Beyond neuropsychological measures o f EF, self- 
report scales may be useful in assessing and identifying individuals with depression. 
Multiple subscales o f  the self-report Deficits in Executive Functioning Scale have been 
found to be significant predictors o f participants’ level o f depression (Knouse, Barkley, &
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Murphy, 2013). However, these researchers found the objective battery o f  EF tests 
administered was only weakly related to depression scores.
Previous research has identified multiple factors as being associated with 
significant deficits and declines in EF. Some o f the main causes o f  impairment and 
deterioration in EF abilities include aging, brain injury, and substance use. During the 
normal aging process, executive cognitive abilities related to the frontal-parietal network 
decline significantly (Burzynska et al., 2012). Additionally, cortical thickness in specific 
brain regions o f  older adults has been found to be predictive o f performance on measures 
o f  EF (W isconsin Card Sorting Test; Burzynska et al., 2012).
In addition, individuals who were exposed to alcohol prenatally exhibit significant 
impairments in EF when compared to controls. Specifically, children with prenatal 
alcohol exposure have reduced attentional and response inhibition abilities (O ’Brien et 
al., 2013). These researchers found that alcohol-exposed children exhibit reduced neural 
activity, in the precentral and postcentral gyri, and behavioral deficits in cued no-go 
response trials o f  a response inhibition task (O ’Brien et al., 2013).
Moreover, an individual’s level o f  EF is often estimated by performance on 
neurocognitive tests, such as the Trail-Making Task, Wisconsin Card Sorting Test, and 
the Stroop Color-W ord Interference Test. However, Barkley (2011) argues that self- 
report scales may be more valid measures o f  problems performing daily tasks and 
achieving goals when compared to formal tests. Barkley (2011) postulates that there are 
several important advantages to using a self-report measure compared to using either 
objective assessments o f EF or direct observation o f  patients. For example, rating scales 
allow for the measurement o f extremely infrequently exhibited problematic behaviors and
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allow for the vast experience o f  an individual across a variety o f  settings to be considered 
and estimated which cannot be efficiently done using formal neuropsychological testing 
practices (Barkley, 2011).
Substance Abuse 
Substance Abuse and Psychiatric 
Impairment
The associations between psychosocial problems and impairments in EF have 
been extensively examined. Relatedly, research has clearly found high levels of 
comorbidity with several behavioral problems and psychological disorders being 
frequently connected to substance abuse, and evidence suggests that these associations 
may influence, and be impacted by, EF and prefrontal cortex processes. For example, 
personality disorders are four times more likely to be diagnosed in substance abusers 
compared to healthy controls (Armstrong & Costello, 2002). Likewise, higher levels o f 
neuroticism and impulsivity have been found to be associated with increased substance 
use (Terracciano, Lockhenhoff, Crum, Bienvenu, & Costa, 2008). And for men, 
irritability has been found to mediate the relationship between executive functions and 
alcohol-related aggression in a sample o f  social drinkers under the age o f  35 (Godlaski & 
Giancola, 2009).
Substance use also has been found to be associated with a number o f  other 
psychological disorders, including mood disorders (both depressive and bipolar 
disorders) and some anxiety disorders (Verdejo-Garcia et al., 2004; Wittchen et al.,
2007). Verdejo-Garcia et al. (2004) explain that the high comorbidity involving substance 
abuse has been conceptualized in two broad ways. The self-medication hypothesis 
proposes that depression may be a motivation for substance usage (Weiss, Griffin, &
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Mirin, 1992) while other researchers suggest that mood disorders develop as a result o f 
neural changes within monoamine projection pathways caused by drug abuse (Verdejo- 
Garcia et al., 2004).
Further, impulsive personality traits have been found to be associated with EF test 
performance for a sample o f  substance-dependent individuals (Dolan, Bechara, &
Nathan, 2008). Also, drug-dependent cocaine-abusers often report manic-like symptoms 
and tend to exhibit a borderline/antisocial personality pattern (Rosselli, Ardila,
Lubomski, Murray, & King, 2001). However, these researchers found no relationship 
between neuropsychological functioning and personality problems (Rosselli et al., 2001). 
In contrast, other researchers have found that individuals with comorbid antisocial 
personality disorder perform significantly worse on neuropsychological measures 
suggesting that the presence o f  an additional diagnosis (beyond substance dependence) is 
in some way related to increased impairment (Stevens, Kaplan, & Bauer, 2001). 
Interestingly, these researchers concluded that comorbid antisocial personality disorder 
was a better predictor o f  cognitive impairment compared to the severity o f  use for a 
sample o f  abstinent substance-abusers (Stevens et al., 2001).
Although there exists evidence pertaining to the relationship between problematic 
personality characteristics and substance abuse, there is no clear understanding o f  any 
potential role o f EF in this association. It appears that continuing research is needed to 
further examine how neuropsychological deficits, personality problems, and substance 
abuse are related.
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Substance Abuse and Executive
Functioning
Beyond associations with psychiatric disorders, substance use disorders have also 
been found to be related to other cognitive and behavior problems, especially those 
involving executive functions. Previous research has examined this relationship between 
substance abuse and EF in a number o f different manners. Some researchers have studied 
the connection between specific drugs and exhibited patterns o f  cognitive deficits while 
others have focused their investigations on determining how intensity o f  exposure and 
length o f usage influence functioning and impairment. However, some ambiguous or 
incomplete results have been demonstrated in previous research. This may be due to 
many studies in this area only examining users o f one substance and few simultaneously 
analyzing more than two substances with the same measures. It is also critical to consider 
the characteristics of, and differences between, the acute, residual, and long-term effects 
o f  particular substances. Additionally, the direction o f causation between functioning and 
substance use has been considered. Overall, there exists clear evidence that substance 
abuse and dependence is associated with significant neuropsychological impairments 
across a number o f cognitive domains (Verdejo-Garcia et al., 2004).
Importantly, researchers have identified and organized maladaptive behaviors 
exhibited by substance-dependent individuals which are related to EF (Bechara et al., 
2001; Verdejo-Garcia et al., 2004). These problematic behaviors have been divided into 
three components, the first being an expectation based on reward predictions and 
attributions o f reinforcing properties to the drug. Also, addicts experience a motivational 
state wherein a compulsive drive is exhibited. The final element o f this process is a 
decision-making component in which the expectations o f immediate reward are
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considered in comparison to possible long-term negative consequences. Substance- 
dependent individuals exhibit deficits in these specific processes, and researchers have 
proposed that these behavioral maladaptations represent impairments in EF, especially in 
decision-making abilities (Verdejo-Garcia et al., 2004).
These maladaptive behaviors are believed to be associated with the orbitofrontal 
cortex and involve the computation o f  motivational valences (Bechara et al., 2001; 
Verdejo-Garcia et al., 2004). Notably, substance abusers share two problematic 
behavioral markers with patients suffering from orbitofrontal damage, both frequently are 
unaware, or deny the existence, o f the problems they experience and members o f  both 
groups frequently disregard long-term consequences when they seek and choose 
immediate rewards over possible long-term benefits (Bechara et al., 2001).
Although it is generally believed that substance use causes cognitive deficits, 
Giancola and Tarter (1999) argue that for some individuals executive cognitive 
dysfunction may precede substance abuse. It has been proposed that cognitive 
functioning impairments in individuals may be a critical vulnerability factor in the 
development o f substance use disorders and related behaviors. For example, components 
o f  EF, such as impulsivity, may mediate the development o f drug dependence in rats 
(Belin, Mar, Dailey, Robbins, & Everitt, 2008). Additionally, Day, Metrik, Spillane, and 
Kahler (2013) conclude that frequent cannabis users with executive cognitive deficits 
(lower working memory and higher impulsivity) may be more likely to develop or 
experience significant marijuana-related problems compared to users without such 
cognitive problems. Moreover, executive cognitive functioning in late childhood has been 
found to be predictive o f  adolescent drug use for individuals classified as high-risk
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(Aytaclar, Kirisci, Tarter, & Lu, 1999). Likewise, childhood neurobehavioral 
disinhibition has been found to be predictive o f  substance use disorder problems in early 
adulthood (Tarter et al., 2003) while response inhibition in childhood is related to 
adolescent drug and alcohol use problems (Nigg et al., 2006).
In addition, poorer planning ability has been found to be associated with increased 
sharing o f  drug use equipment. Specifically, impaired performance on the Tower o f 
London task was found to moderate the relationship between the frequency o f  injection 
drug usage and the occurrence o f  sharing o f  paraphernalia (Severtson, Mitchell. Mancha, 
& Latimer, 2009). Further, Dolan et al. (2008) found substance-dependent participants 
exhibited significantly poorer EF, specifically lower scores on a decision-making task 
(Iowa Gambling Task), when compared to controls. Interestingly, these researchers found 
that the existence o f  a family history o f  substance abuse was related to an increased risk 
o f  impairment. Other researchers have argued that poorer EF and decision-making 
abilities are related to possible problems effectively making decisions in abstinence 
related to future drug use and greater likelihood o f  return to usage (Almeida & Monteiro, 
2014).
There exists evidence that extensive use o f a variety o f illicit drugs, including 
alcohol, opiates, cannabis, and stimulants, can lead to deficits in a number o f  areas o f  EF, 
and the particular deficits, including the severity o f  impairment, experienced are 
substance-dependent for many individuals (Verdejo-Garcia, et al., 2004). For example, 
Omstein et al. (2000) found distinct patterns o f  cognitive problems for amphetamine and 
heroin addicts, which suggests dysfunction in diverse areas o f the cortico-striatal 
circuitry. Overall, substance-dependent individuals consistently experience and exhibit
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more generalized executive dysfunction when compared to individuals designated as 
recreational drug users (Verdejo-Garcia & Perez-Garcia, 2007).
The functioning o f individuals who moderately or infrequently use drugs and 
alcohol, as well as those who binge, has been investigated with mixed results. In one 
study (Piechatzek et al., 2009), a substance use group was examined which consisted o f 
mild to moderate users o f  ecstasy, cannabis or alcohol. Limited differences were found 
between a control group and this substance use group on multiple measures o f  cognitive 
functioning, including EF. In contrast to these results, rave-attending polysubstance users 
were found to exhibit specific EF deficits, such as decreased perseverance and increased 
impulsivity, when compared to healthy controls (Verdejo-Garcia et al., 2010).
Additionally, binge drinking may be associated with cognitive deficits. In one 
study, college students who reported engaging in binge drinking behaviors were found to 
perform significantly worse on measures o f  EF, specifically lower scores on the 
Backward Digit Span task and higher levels o f  perseverative responses, when compared 
to controls (Parada et al., 2012). Furthermore, these researchers found male binge 
drinkers exhibited even more severe impairments compared to female binge drinkers on 
some measurements (Parada et al., 2012).
Gender does appear to impact the level o f severity o f  cognitive impairments 
caused by substance abuse. Research indicates that males experience more severe neural 
effects from chronic drug use (Kaufman et al., 2001). For example, drug-using males 
have been found to exhibit higher levels o f  cognitive impairment in visual working 
memory than females (Ersche, Clark, London, Robbins, & Sahakian, 2006).
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Specific drugs have been found to be associated with certain patterns o f  deficits 
indicating that it may be critical to consider and study substances independently, 
whenever possible. Alcohol usage is very common among both illicit substance users and 
other adult groups. Wittchen et al. (2007) found a cumulative incidence rate o f alcohol 
use o f  over 95% within a sample o f  young adults. Further, chronic alcohol use is 
associated with changes in specific brain areas, such as atrophy o f the frontal lobes and 
hypometabolism in the frontal cortex, and leads to cognitive dysfunction (Zinn, Stein, & 
Swartzwelder, 2004). The review o f Oscar-Berman and Marinkovic (2007) concludes 
that the neocortex, limbic system, and cerebellum are the neural structures most 
vulnerable to alcohol abuse.
A majority o f alcohol-dependent individuals suffer from mild to moderate 
neurocognitive impairment (Bates, Bowden, & Barry, 2002). In one sample o f  alcohol 
abusers evaluated in early abstinence, multiple cognitive deficits were exhibited, 
including episodic memory and executive function impairments. Specifically, the 
alcoholic inpatients examined displayed impairments in all executive areas studied, 
including updating, flexibility, inhibition, organization (verbal fluency), and integration 
(Pitel et al., 2007). Further, in a sample o f  polysubstance-users, alcohol abuse was found 
to be related to poorer decision-making skills, as well as deficits in fluency (Femandez- 
Serrano, Perez-Garcia, Schmidt Rio-Valle, & Verdejo-Garcia, 2010).
Zinn et al. (2004) also found deficits in early abstinence when alcohol-dependent 
individuals were compared to a control group. The alcohol-dependent group exhibited 
significantly lower performances in both abstract reasoning and cognitive flexibility. The 
pattern o f memory problems o f alcohol-dependent participants included retrieval issues
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but not learning or retention difficulties. These researchers concluded that this pattern 
suggests frontal lobe deficits. Also, members o f  the alcohol group self-reported 
experiencing significantly more cognitive impairments when compared to the healthy 
control group (Zinn et al., 2004).
Opioid abuse and dependence has been shown to be related to problems in a 
number o f cognitive domains, including attention, memory, and executive function 
(Omstein et al., 2000; Rapeli et al., 2006). Specifically, Rapeli et al. (2006) examined 
early abstinence functioning (with assessment occurring between 5 and 15 days after last 
opioid usage) in a sample o f opioid dependent individuals. These researchers found 
deficits in executive functions (as measured by the Stroop Task and Ruff Figural Fluency 
Test), fluid intelligence, and complex working memory (Paced Auditory Serial Addition 
Test) when compared to healthy controls. However, no deficits were found in episodic 
memory or simple working memory, as measured by the Digit Span task (Rapeli et al.,
2006). Sustained attention also appears to be impacted by the abuse o f opiates. 
Researchers have observed significantly poorer performance on a measure o f  sustained 
attention for both methadone-maintained subjects and individuals previously dependent 
on opiates now in protracted abstinence when these groups were compared to healthy 
controls (Prosser, London, & Galynker, 2009).
Ersche et al. (2006) found that opiate dependent individuals exhibit impairments 
in visual memory and planning ability (Tower o f London). Interestingly, the subjects 
studied exhibited no dysfunction on an attentional set-shifting task (Three-Dimensional 
Intra/Extra Dimensional Set Shift). Similarly, Guerra, Sole, Cami, and Tobena (1987) 
found deficits in working memory, attention, and verbal fluency in individuals currently
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abusing heroin. Further, Gerra et al. (1998) did not find significant differences between a 
control sample and abstinent opiate-abusers on two neuropsychological tests. At four 
months o f abstinence there were no differences between groups on the Digit Symbol and 
Category Test suggesting cognitive improvements occur within the first few months after 
usage has ceased.
In addition, extensive use o f  cannabis has also been found to be associated with 
multiple cognitive deficits. Users exhibit significantly more perseveration, decreased 
mental flexibility, and lowered ability to sustain attention (Lundqvist, 2005). Adolescent 
and young adult cannabis users have been found to exhibit retrieval and immediate verbal 
memory deficits (Takagi et al., 2011). Adolescent cannabis users also produce reduced 
psychomotor speed, poorer complex attention, and reduced planning and sequencing 
abilities in comparison to control group performance (Medina et al., 2007). Similarly, an 
additional study compared long-term adolescent cannabis users with two control groups, 
one o f which consisted o f healthy controls while the other was composed o f  drug users 
that were not long-term cannabis users. Schwartz, Gruenewald, Klitzner, and Fedio 
(1989) found significant differences between the two control groups and the cannabis 
group on two measures o f  short-term memory (auditory/verbal and visual/spatial) with 
the cannabis-using group producing poorer scores. Further, when comparing individuals 
who began cannabis use before the age o f  15 and those that started usage after 15 years o f 
age, the EF performance o f late-onset users was superior to early-onset cannabis users 
(Fontes et al., 2011). These findings suggest that earlier usage o f  cannabis may result in 
more extensive impairment.
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Although there is strong empirical support that substance use causes long-term 
neuropsychological impairments, clearly many addictive, as well as illicit, drugs have the 
capacity to provide positive acute effects. For example, stimulants have been found to 
enhance human performance within a number o f  areas, such as decreasing fatigue, 
increasing vigilance and processing speed, and prolonging effort (Koelega, 1993).
Further, intermediate doses o f cocaine have been found to facilitate performances on 
measures o f inhibitory control (stop-signal task and cue-dependent go-no-go task). 
However, increased doses do not produce improvements and likely lead to impairing 
effects (Fillmore, Rush, & Hays, 2006). Critically, cocaine abusers experience 
impairments in cognitive flexibility, learning, memory, decision-making, response 
inhibition, and attention (Lundqvist, 2005; Sofuoglu, Waters, Poling, & Carroll, 2011). 
Interestingly, in one study assessing cocaine and heroin addicts, polysubstance abusers 
whose drug o f choice was cocaine have been found to exhibit significantly more impaired 
scores on measures o f  response inhibition and flexibility compared to polysubstance 
abusers whose reported drug o f  choice was heroin (Verdejo-Garcia & Perez-Garcia,
2007).
There also exists clear evidence that the abuse o f other drugs o f  addiction may 
lead to significant deficits in functioning. For example, in a sample o f  current 
methamphetamine users, Simon et al. (2000) found deficits in working memory 
(updating), response inhibition, and mental flexibility. Also, deficits in planning ability 
and visual memory have been found in amphetamine abusers (Ersche et al., 2006). 
Additionally, adolescent and young adult inhalant users exhibit significant impairment in 
memory retrieval, learning performance, and verbal memory (Takagi et al., 2011).
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Length and Severity o f Usage. There have been attempts to investigate the 
influence o f  severity and length o f  substance abuse on levels o f  impairment. For example, 
in one sample o f opiate and amphetamine users, years o f usage was found to not be 
related to level o f  executive function impairment (Ersche et al., 2006). In contrast, more 
severe working memory and attentional impairments have been found to be associated 
with longer durations o f  alcohol dependence (Loeber et al., 2009). Individuals dependent 
on alcohol for more than nine years exhibited significantly greater impairment compared 
to individuals whose length o f  dependence was not as prolonged. These researchers also 
found that the ability to shift among mental sets was not associated with length o f time o f 
alcohol abuse (Loeber et al., 2009). Moreover, dose peak o f substance usage has been 
found to be negatively related to attention and executive function (Sclafani, Tolou- 
Shams, Price, & Fein, 2002).
Additionally, a study examining abstinent polysubstance users (with a mean 
duration o f  abstinence o f  five months) observed that poorer updating abilities (as 
estimated by measures o f  working memory, fluency, and reasoning) were predicted by 
greater severity o f  usage (Verdejo-Garcia & Perez-Garcia, 2007). Also, severity o f  opioid 
dependence has been found to be associated with greater impairment in task-shifting 
abilities and increased perseverative responses and errors (Lyvers & YakimofT, 2003). 
Overall, it is apparent that research related to the association between EF deficits and 
length and severity o f  substance use is inconclusive and further investigation is 
warranted.
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Executive Functioning and Improvement 
during Abstinence
Another associated line o f  investigation examines the extent to which cognitive 
abilities and executive functions improve during early and sustained periods o f 
abstinence. There exists evidence that certain cognitive functions may improve with 
extended abstinence while other abilities may remain dysfunctional and an individual’s 
drug o f  choice could be influential in the eventual pattern o f  abilities observed.
Within several weeks o f  abstinence, functional and structural brain damage has 
been found to be partially reversible for alcohol-dependent individuals (Crews et al.,
2005; Oscar-Berman & Marinkovic, 2007). There is evidence that within approximately 
four years o f  abstinence, former alcoholics will likely experience significantly increased 
perfusion within the left frontal lobes similar to normal levels o f  blood flow (Gansler et 
al., 2000). Further, in a sample o f  long-term abstinent individuals (average years o f 
abstinence 6.7 years), significant neuropsychological deficits were not present when 
compared to normal controls, as estimated by performance on measures o f  cognitive 
flexibility, attention, and auditory working memory. The only impairment observed after 
extended abstinence was in spatial processing (Fein, Torres, Price, & Sclafani, 2006). 
Additionally, research suggests that specific cognitive deficits (such as working memory 
and verbal fluency) will diminish within three to six weeks o f cessation o f usage for 
alcoholics (Crews et al., 2005; Mann, Guenther, Stetter, & Ackermann, 1999; Manning et 
al., 2008; Oscar-Berman & Marinkovic, 2007).
Similarly, Manning et al. (2008) examined alcohol-dependent inpatients within 
the first week o f  intake and after detoxification, during the fourth week o f treatment. 
Significant improvements were found for full-scale IQ (as measured by the WASI),
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working memory (Letter-Number Sequencing), verbal fluency (Verbal Fluency Test), 
and verbal inhibition (Hayling Sentence Completion). However, mental flexibility and 
attentional set-shifting (as measured by the Intra/Extra Dimensional Set Shift) and visual 
planning ability (Stockings o f  Cambridge Test) did not improve at follow-up (Manning et 
al., 2008).
In a study o f  male alcohol-dependent patients, Mann et al. (1999) found 
significant improvements at five-week re-test on four o f  the five Halstead Reitan Battery 
domains that were dysfunctional during the first week o f  treatment. These results suggest 
that significant improvements in multiple cognitive abilities can occur within six weeks 
o f  addiction treatment for alcoholics. In addition, Zinn et al. (2004) found that nonverbal 
abstract reasoning was related to length o f  abstinence with higher performance associated 
with the number o f  days o f sobriety for abstinent alcoholics.
In comparison, research is conflicted pertaining to how quickly impairments are 
alleviated for opiate-dependent individuals, although Rapeli et al. (2006) propose that 
opioid dependent individuals may regain some cognitive abilities, specifically increased 
working memory performance, after a period o f  abstinence. Evidence suggests 
improvements occur within nine months (Gerra et al., 1998; Mintzer, Copersino, & 
Stitzer, 2005), and global deficits are not apparent at six weeks o f abstinence (Rapeli et 
al., 2006). One study (Gerra et al., 1998) even indicates that significant improvements 
can come about within one week o f  detoxification. Additionally, M intzer et al. (2005) 
conclude that general cognitive recovery may occur for abstinent opioid abusers. 
However, these researchers suggest that methadone maintenance may lead to additional 
impairment for individuals recovering from opioid dependence when using this medical
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treatment as a means o f reducing or eliminating illicit opioid usage. Abstinent opioid 
abusers (mean abstinence o f nine months) exhibited significantly better scores compared 
to methadone-maintained individuals on the Recognition Memory Test and the Trail- 
Making Task while there were no differences found on several other measures (Mintzer 
et al., 2005). Relatedly, Prosser et al. (2009) found that methadone-maintained 
individuals exhibited poorer sustained attention scores when compared to abstinent 
opiate-dependent participants. Similarly, King and Best (2011) found a negative 
relationship between level o f methadone dosage and overall intelligence quotient (IQ) in 
a sample o f  problem drug users receiving treatment.
In contrast, when examining both current and former users (abstinence over one 
year) o f  opiates or amphetamines, there were no differences on visual memory or 
planning tasks based on length o f  abstinence (Ersche et al., 2006). These researchers 
concluded that neurocognitive impairment continues for several years during individuals’ 
abstinence and indicates damage in the frontal cortex. Moreover, in a sample of 
polysubstance-dependent males, increasing abstinence was not related to improved 
neurocognitive functioning (Medina, Shear, Schafer, Armstrong, & Dyer, 2004).
A sample o f  long-term cannabis-abusing adolescents was tested at six weeks o f 
supervised abstinence. This sample exhibited positive, but non-significant, improvements 
on two measures o f short-term memory at six weeks when compared to scores at intake 
thus supporting the idea that some deficits may remain for an extended period o f time 
after stopping cannabis usage (Schwartz et al., 1989). In a sample o f former heroin and 
cocaine users with a mean average o f  five months o f abstinence, significant impairments 
in inhibition, decision-making, updating, and shifting were evident. Further, the level o f
33
impairment was greater for the cocaine group on measures o f  shifting and inhibition 
compared to the heroin-dependent sample (Verdejo-Garcia & Perez-Garcia, 2007).
Sclafani et al. (2002) examined abstinent individuals previously abusing either 
crack-cocaine or both crack-cocaine and alcohol. When assessed during abstinence (at 
both six weeks and six months) the two groups continued to exhibit significant 
impairments in multiple functions, including inhibition, memory, and verbal fluency. 
Overall, there appears to be clear evidence that not all cognitive and executive 
functioning abilities will return to previous levels following a period o f sustained 
abstinence.
Executive Functioning and Substance 
Abuse Treatment
There exists limited research concerning how problems in various cognitive 
domains influence one’s ability to successfully complete psychosocial treatments.
Deficits in EF have been found to be related to multiple treatment-related variables for 
individuals undergoing substance abuse treatment, including treatment retention, 
completion, and relapse (Aharonovich et al., 2006; Morrison, 2011; Verdejo-Garcia et al., 
2012). In general, findings suggest that impairments caused by substance abuse can 
negatively affect treatment response. However, there is minimal research specifically 
examining how increases in neurocognitive functioning observed during an abstinent 
rehabilitation period are associated with treatment response and outcome.
In a study examining treatment retention o f cocaine-dependent participants, 
Verdejo-Garcia et al. (2012) observed that poorer EF was significantly predictive o f 
fewer days spent in therapeutic communities. Specifically, the best predictor was scores 
on the Revised-Strategy Application Test, which measures one’s ability to multitask and
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organize sub-goals during the achievement o f a long-term goal. Similarly, reduced 
treatment retention o f cocaine-dependent subjects has been found to be correlated with 
perseverative errors on a measure o f problem-solving (Wisconsin Card Sorting Test). 
However, no other cognitive measures were associated with treatment progression in this 
study (Turner, LaRowe, Homer, Herron, & Malcolm, 2009). Streeter et al. (2008), using 
a logistic regression analysis, found that a measure o f  cognitive control and inhibition, 
the Stroop Color-Word Interference Test, was able to significantly predict membership 
within the two examined groups, treatment completers and non-completers.
In another study (Aharonovich et al., 2006), researchers compared individuals 
who completed substance abuse treatment (defined as 12 or more weeks o f  cognitive- 
behavioral therapy) to those who prematurely withdrew on a number o f  variables. Their 
results indicated that the individuals who did not fully complete the substance abuse 
treatment program had significantly poorer cognitive functioning, in the areas o f 
attention, memory, speed, accuracy, spatial ability, and global functioning, when 
compared to those individuals who were able to successfully complete treatment. 
Interestingly, there were no differences between these groups on the Wisconsin Card 
Sorting Test suggesting that certain executive functions may be more influential in the 
treatment process for substance-dependent individuals than other abilities (Aharonovich 
et al., 2006).
Moreover, Rinn, Desai, Rosenblatt, and Gastfriend (2002) propose that denial o f 
significant problems related to alcohol usage may sometimes be associated with cognitive 
dysfunction instead o f  a manifestation o f  an ego defense mechanism. These researchers 
found that the number o f  denial-related treatment goals utilized by clinicians was
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significantly correlated with multiple cognitive deficits, including poorer executive 
functions, verbal memory, and mental slowness (Rinn et al., 2002).
Morrison (2011) examined the relationship between neuropsychological 
functioning, after 5 to 10 days within an inpatient detoxification unit, and rate o f  relapse 
for participants at 3-month follow-up. Specifically, verbal learning (Rey Auditory Verbal 
Learning Test), working memory (Letter-Number Sequencing Test), and EF performance 
(Trail-M aking Task B) were significantly and negatively correlated to the number o f days 
o f  drinking alcohol. Further, EF was a significant predictor o f days o f drinking at three 
month follow-up with better cognitive functioning related to fewer days o f consumption 
(Morrison, 2011).
Because o f  the apparent negative effects cognitive deficits have on therapy, some 
researchers are beginning to examine medical treatments for specific cognitive problems 
exhibited by substance-dependent individuals. For example, Sofuoglu et al. (2011) 
administered Galantamine, a medicinal treatment for Alzheimer’s dementia, to a sample 
o f chronic cocaine users for ten days. The cocaine users who received the Galantamine 
exhibited improved scores on a measure o f  sustained attention (Sofuoglu et al., 2011).
In addition, general functioning o f  substance abusers may be influenced by their 
cognitive deficits. For example, deficits in attention have been found to be predictive o f 
employment problems in a sample o f  substance abusers receiving outpatient treatment 
(Mackin, Homer, Harvey, & Stevens, 2005). These researchers suggest that 
neuropsychological testing may be useful in differentiating substance abusers with 
potential for risk o f employment problems during abstinence.
36
Blume et al. (2005) examined associations between executive cognitive functions 
and motivation and readiness to change drinking behavior in a sample o f  alcohol abusers. 
These researchers found that contemplation to change was related to higher verbal 
memory scores. Further, better attention-concentration skills were predictive o f lower 
levels o f drinking behavior at follow-up measures during abstinence.
It has been proposed that impairments in decision-making, memory, and problem­
solving skills are likely to reduce the ability o f  certain substance-abusing individuals to 
effectively participate in treatment (Blume & Marlatt, 2009). These researchers argue that 
executive cognitive functioning should be considered an important factor in treatment 
planning and implementation as engagement and appropriate participation may be 
affected and relapse more likely for those with deficits.
Verdejo-Garcia, et al. (2004) explain how cognitive impairments may negatively 
impact treatment in two important ways as they may increase the likelihood o f drug- 
seeking behaviors and may interfere with an individual’s participation in, and 
understanding of, rehabilitation programs with an educational or cognitive emphasis. 
Investigating EF o f  substance abusers in treatment may be especially important since 
counselors are ineffective at identifying clients with cognitive impairments (Fals-Stewart, 
1997).
Another factor to consider is the utilization o f  self-report measures o f  executive 
functioning in assessments as they are likely to be quicker, cheaper, and more easily 
administered to individuals with potential substance use disorders. The majority o f 
research examining deficits o f  substance abusers emphasize performance on 
neuropsychological measures o f  cognitive and executive functions with minimal research
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considering the utility o f  self-report measures in assessing EF problems. However, in a 
sample o f college students, problematic substance users have been found to score 
significantly different that non-problematic users on self-report measures o f EF problems 
(Brunelle & Flood, 2016). Another found a self-report measure (Behavior Rating 
Inventory o f Executive Functioning) to be more sensitive than a performance-based 
measure in differentiating a substance abuse group from a control group (Hagen et al., 
2016). These findings support the continued research and utility o f including these types 
o f assessments in neuropsychological evaluations o f substance abusers.
Overall, there exists evidence that within several weeks to years o f  abstinence 
certain cognitive abilities, and executive functions, are likely to improve for substance- 
dependent individuals. Verdejo-Garcia, et al. (2004) claim that neuropsychological 
functions begin to recover within the first month o f  abstinence for substance abusers. 
There is also evidence indicating that EF impairment can have a negative effect on 
treatment response. However, there appears to be no clear understanding as to how 
observed deficits and improvements are related to ongoing substance-related problems, 
personality characteristics, and treatment response, and it is apparent that further research 
is needed in order to better estimate the type, speed, and extent o f  improvements in 
functioning for abstinent substance-abusers.
The Present Study
The primary purpose o f the present study was to further examine the relationship 
between substance abuse and executive cognitive functioning. Specifically, cognitive 
performance o f  substance abusers was analyzed and the relationship between self-report 
measures and neuropsychological test performance was considered. A three-factor model
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o f EF (including set-shifting ability, response inhibition, and working memory) was 
investigated. Furthermore, changes in functioning were evaluated in participants 
undergoing residential substance abuse treatment.
Multiple EF constructs, as well as other cognitive abilities, were measured 
including: planning ability, set-shifting/cognitive flexibility, working memory, inhibition, 
verbal fluency, sustained attention, and general intelligence. In addition to 
neuropsychological measures, self-reported cognitive and executive functioning problems 
and perceived problematic personality traits were assessed, along with level o f substance- 
related problems. Although there exists extensive research investigating the impairments 
in neurocognitive functioning o f substance abusers, there appears to be a need to further 
elucidate any changes in functioning during early abstinence and potential predictors o f 
treatment response. Further, the sample evaluated in the present study is likely to be 
markedly different from most research in this area. Previous research at this facility found 
the average Full Scale IQ among over 150 referral patients to be 110 (Tracy & Young, 
2012). With such a unique population likely possessing higher premorbid cognitive 
functioning compared to similar investigations, fewer cognitive deficits may be 
identified.
Hypotheses
Hypothesis One. It is hypothesized that self-reported problems related to 
executive functions (as measured by the BDEFS) will be negatively associated with 
multiple neuropsychological measures o f functioning (LNS, COWA, CTMT, SNST, 
GDS, and ToL scores).
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Hypothesis Two. It is hypothesized that participants will exhibit deficits at intake 
compared to established norms in multiple EF areas, including planning ability (as 
measured by ToL scores), set-shifting (CTMT scores), working memory (LNS scores), 
inhibitory control (SNST scores), and verbal fluency (COWA scores), as well as 
sustained attention (GDS scores). Further, participants will likely report increased EF 
problems (BDEFS scores) when compared to normative samples.
Hypothesis Three A. It is hypothesized that participants will make significant 
improvements in EF after detoxification and increasing abstinence at 45 days. More 
specifically, it is predicted that significant improvements in working memory (LNS 
scores), verbal fluency (COWA scores), set-shifting (CTMT scores), inhibition (SNST 
scores), and self-reported EF problems (BDEFS scores) will be exhibited at follow-up 
testing (45 days).
Hypothesis Three B. It is also hypothesized that significant changes in planning 
ability (ToL scores) and sustained attention (as measured by the GDS) are not expected at 
follow-up.
Hypothesis Four. It is hypothesized that longer duration o f substance usage prior 
to treatment, substance-related behaviors and problems (AUDIT and SIP-D scores), and 
level o f problematic personality traits (BAT-37 scores) will be predicted by more deficits 
in neurocognitive functioning across measured domains (scores on GDS, LNS, ToL, 
COWA, SNST, and CTMT) and self-report EF problems (BDEFS) at intake.
Hypothesis Five. It is hypothesized that higher performance-based scores and 
lower self-report deficits in EF at initial testing will be associated with treatment 
progression, as measured by retention at follow-up testing point.
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Clinicians, including study investigators, have observed patients exhibit increased 
abilities to maintain attention, track conversations, organize treatment-related work, and 
participate effectively in treatment as they progress through a residential treatment 
program. These hypotheses are designed in order to further understand the observed 
improvements in cognitive functioning that appear to occur early in treatment and 




The present study utilized a repeated measures design to identify possible changes 
in cognitive functioning and EF o f  inpatients undergoing substance abuse treatment. All 
incoming residential clients were considered for inclusion in this study and all willing 
clients were included as none met exclusion criteria. In order to estimate necessary 
sample size, a power analysis for an ANOVA was conducted. Based on the procedure o f 
Manning et al. (2008), to detect a moderate effect size with approximately 80% power, a 
sample size o f  30 participants is required (Friendly, 2012). Approximately 40 substance- 
abusing participants were included for the full study. Further, the institutional review 
boards o f the university and the participating addiction treatment facility approved the 
materials and procedures o f  this study.
Participants
Participants were males (N = 20) and females (N = 20) between the ages o f  19 
and 60 years old who were recruited from a private residential addiction treatment facility 
within the southeastern United States, and participation in this study was completely 
voluntary. Participants were voluntarily seeking treatment for a substance use disorder (as 
identified by meeting DSM-IV criteria) and multiple individuals were compelled by a 
licensing board to undergo treatment. Two major exclusion criteria were active
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psychosis, as observed by facility personnel or reported by the potential participant, and 
an initial treatment plan consisting o f less than 60 days o f  residential treatment. 
Approximately 40% o f the patients at this facility are professionals referred by their 
supervisory board for evaluation/treatment and 25% o f the study sample reported seeking 
treatment in order to maintain current job  status. A proportion o f recruited participants 
did not remain at the facility for the complete residential treatment program, or a 
sufficient number o f  days to be re-assessed as part o f  this project. These participants 
ceased treatment prematurely and were only evaluated at intake and data for these 
individuals were included and analyzed where appropriate. O f the overall sample, 21 
participants were re-administered the measures o f  neurocognitive functioning (BDEFS, 
SNST, CTMT, ToL, LNS, COWA, and GDS) and the measure o f  disordered personality 
characteristics (BAT-37) with the mean number o f days between testing being 44.7 (SD 
= 4.17).
Treatment Facility
The addiction treatment center where this study was conducted is based on a 12- 
Step, abstinence-based model. Patients progress through four phases o f  treatment by 
achieving specific treatment objectives, such as completing a series o f  standard treatment 
assignments. It is a residential facility primarily providing 90 days o f  treatment, although 
a minority o f patients have a treatment recommendation o f  only 60 days. Patients receive 
daily psychoeducation concerning substance use and other psychiatric disorders. They 
participate in at least nine group therapy sessions per week with their specific group and 
primary counselor, as well as multiple Alcoholics Anonymous meetings weekly. They
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are also provided with complete medical care, through which detoxification is monitored, 
from physicians and additional medical personnel.
Instruments
Demographic Questionnaire. A demographic questionnaire was used to collect 
information on general characteristics o f  the participants, such as age, sex, race/ethnicity, 
profession, and educational history, as well as other personal information. Other items 
asked participants to indicate the primary reason for their admission into treatment. 
Additional items assessed length o f  substance usage, specific substances used, drug o f 
choice/major problem drug, and days since last usage.
Alcohol Use Disorders Identification Test (AUDIT). The AUDIT (Babor, De la 
Fuente, Saunders, & Grant, 1989) was designed as a screening instrument to identify 
individuals with possible alcohol use disorders. The self-report version o f the AUDIT 
contains 10 questions primarily assessing frequency o f  alcohol-related behavior and 
problems within the last year, such as “How often do you have six or more drinks on one 
occasion?” A majority o f these items are answered on a scale ranging from 0 (never) to 4 
(idaily or almost daily). Higher scores indicate greater likelihood o f alcohol dependence. 
The AUDIT also provides cut-off scores which classify drinkers into one o f  four levels 
indicating level o f hazardous drinking and need for intervention. The AUDIT has 
exhibited favorably sensitivity and acceptable specificity across multiple cultures based 
on ICD-10 alcohol use disorders. Concurrent validity is indicated by AUDIT scores 
exhibiting strong correlations with other alcohol screeners. Further, the AUDIT exhibits 
good test-retest reliability (r =.86) and high internal consistency (Babor, Higgins-Biddle, 
Saunders, & Monteiro, 2001). Although the AUDIT is often incorporated into a
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diagnostic interview, it has been found to be effective in identifying individuals with 
possible alcohol problems as a self-report scale (Babor et al., 2001).
In the present study, the self-report form o f the AUDIT was utilized as a measure 
o f level o f  alcohol-related behaviors and problems. Participants were not classified into 
levels, instead the variable o f interest was total aggregate score with higher scores 
associated with more severe alcohol-related problems.
Short Index o f Problems-Drugs (SIP-D). The SIP-D (Alterman, Cacciola, Ivey, 
Habing, & Lynch, 2009) is a 15-item scale based on the Drinker Inventory o f 
Consequences (DrlnC; Miller, Tonigan, & Longabaugh, 1995). It was developed to 
measure an individual’s negative consequences associated with drug use within the past 
three months. The SIP-D utilizes items from five domains; physical, social, intrapersonal, 
impulse control, and interpersonal. Items are answered using a 4-point scale from 0 
(never) to 4 (daily or almost daily). Alterman et al. (2009) found the SIP-D to exhibit 
good internal consistency (Cronbach’s a  -  .97), as well as support for the instrument’s 
concurrent validity. In the present study, the SIP-D was used as a measure o f adverse 
consequences related to drug use. The variable o f  interest was the total score with higher 
scores indicating more drug-related problems.
Barkley Deficits in Executive Functioning Scale-Long Form (BDEFS-LF).
The BDEFS (Barkley, 2011) was originally developed as a self-report measure assessing 
EF in adults with Attention Deficit/Hyperactivity Disorder. It was adapted to measure EF 
within daily life activities o f adults across five identified factors o f EF. Each factor is 
measured by a subscale o f  the BDEFS which contains 89 total items and asks participants 
to rate items on a scale ranging from 1 (never or rarely) to 4 (very often).
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Additionally, the BDEFS-LF has been found to exhibit satisfactory internal 
consistency, with all five subscales having Cronbach’s alpha o f  over .91, for a general 
population normative sample. Further, the test-retest reliabilities at 2-3 weeks were found 
to range from .62 to .90 for the five subscales and the Total EF Summary Score. 
Discriminant validity for the BDEFS has been supported by its ability to distinguish 
clinically-disordered patients, especially adults with ADHD, from general population 
adults (Barkley, 2011).
The BDEFS-LF was utilized as a self-report measure o f EF. It produces scores on 
five subscales o f functioning; Self-Organization/Problem-Solving (items relate to ability 
to organize thoughts and actions and create solutions to problems), Self-Management to 
Time (relates to planning and preparing for goal-directed behavior), Self- 
Restraint/lnhibition (relates to impulsive behavior without considering consequences and 
inability to take other perspectives), Self-Regulation o f  Emotion (involves impulsive 
emotional reactions and ability to calm oneself), and Self-Motivation (involves level o f 
effort in work and getting bored easily). The BDEFS-LF also provides an EF Summary 
score, EF Symptom Count, and ADHD Index score which summarizes overall perceived 
EF capabilities.
Brief Assessment o f Traits -  37 (BAT-37). The BAT-37 (Mayer, 2012) is a 
scale originally developed to measure personality traits considered for DSM-5 personality 
trait criteria. This measurement tool assesses 37 personality facets by asking participants 
to rate a cluster o f three related statements for each facet on a scale ranging from 0 (does 
not describe me at all) to 3 (describes me well). Mayer (2012) described the correlations 
between this assessment and several related scales, indicating support for its construct
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validity. For the present study, the self-report BAT-37 was utilized to briefly screen for 
significant problematic personality characteristics exhibited by participants. Scores o f 2 
or above on any cluster indicate a moderate to high elevation for that particular 
problematic personality trait. The variable o f  interest was total BAT-37 symptom count, 
with higher scores indicating more severe personality characteristics.
W echsler Abbreviated Scale o f Intelligence (WASI). The WASI (Wechsler, 
1999) is a short-form intelligence test designed to take approximately 30 minutes to 
administer. The WASI was used to estimate participants’ levels o f cognitive ability. As 
part o f  the standard evaluation process o f  the treatment facility, referred participants are 
administered this measure o f  both verbal and nonverbal intelligence. The four subtests 
that comprise the WASI are Vocabulary, Similarities, Matrix Reasoning, and Block 
Design. The Vocabulary subtest measures language development, verbal learning ability, 
and word knowledge and asks test-takers to define presented words while the Similarities 
subtest assesses subjects’ ability to explain the similarity between two words or concepts. 
It primarily measures logical abstract thinking, categorical thinking, and crystallized 
knowledge. The Matrix Reasoning subtest measures one’s ability to identify patterns and 
complete sets o f  designs, as well as logic reasoning and abstract reasoning. In the Block 
Design subtest, participants are asked to replicate presented designs using blocks. It is a 
measure o f  spatial visualization and nonverbal concept formation. A full scale 
intelligence quotient (FSIQ) can be calculated using these four subtests. Additionally, a 
verbal intelligence quotient (VIQ) is estimated from the Vocabulary and Similarities 
subtests, and a performance intelligence quotient (PIQ) is determined from the Block 
Design and Matrix Reasoning subtests.
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The WASI IQ index scores have been found to have acceptable internal reliability 
coefficients (.92 to .98). The validity o f the WASI is evidenced by the moderate to high 
correlations (.66, .84, .88, and .92) between same-named subtests o f the Wechsler Adult 
Intelligence Scale - Third Edition (WAIS-III) and the WASI (Wechsler, 1999).
Comprehensive Trail-M aking Task (CTMT). The CTMT (Reynolds, 2002) 
was designed to evaluate brain injuries, specifically frontal lobe damage. In the present 
study, the CTMT was used as a measure o f  set-shifting and divided attention. In this 
series o f  tasks, participants are first asked to connect numbers in ascending order. Then, 
examinees are presented with stimuli containing both numbers and letters and must again 
connect ascending circles in order while alternating between numbers and letters. 
Mistakes are corrected by the exam iner and the total time o f completion was the variable 
o f  interest. Trail-M aking tasks have been found to be sensitive to both dementia and brain 
damage (Smith et al., 2008). The CTMT has been found to exhibit adequate reliability, 
with a coefficient o f  over .90, and discriminant validity (Reynolds, 2002).
Letter-Number Sequencing (LNS). The Letter-Number Sequencing task was 
used primarily as a measure o f working memory (monitoring). In particular, it measures 
mental control, attention, and concentration. The LNS task is a subtest o f  the Wechsler 
Adult Intelligence Scale - Fourth Edition and it exhibits good psychometric properties, 
with an internal consistency coefficient o f  .88, test-retest reliability o f  .76, and factor 
loading on Working Memory o f  .69 (Wechsler, 2008). Further, Beglinger et al. (2005) 
found no significant changes in performance across multiple administrations within a six- 
week period indicating no significant practice effects for this measure. Participants are 
verbally presented with a list o f  unordered items containing both letters and numbers.
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Examinees are asked to verbally respond as they place both the letters and numbers in 
ascending order. The total number o f  correct trials was the primary variable o f  interest, as 
well as the number o f  items with the longest correctly answered sequence, which 
provided an estimate o f one’s working memory capacity.
Controlled Oral Word Association Test (COW A). The COWA (Benton, de 
Hamsher, & Sivan, 1994) is a measure o f verbal fluency designed to determine 
neurocognitive ability. Specifically, it examines an individual’s ability to spontaneously 
produce words beginning with one o f  the three provided letters. Letters were chosen 
based on difficulty and the number o f  words in the English language beginning with each 
letter. It has been found to be sensitive to impairment caused by both brain trauma and 
disease (Ross, Furr, Carter, & Weinberg, 2006). Lower scores have been found to be 
related to bilateral frontal and temporal lobe lesions, dementia, and Korsakoff’s 
syndrome, as well as other psychiatric disorders (Sumerall & Timmons, 1997).
In the present study, the FAS and CFL versions o f  the COWA were used in order 
to attempt to reduce practice effects. In the initial battery, participants were given 60 
seconds in each o f  three trials to generate as many words as they can that begin with the 
letters F, A, and S. The follow-up battery used the letters C, F, and L. The total number o f 
words produced over the three trials was used as the variable o f  interest. Further, Ross et 
al. (2006) concluded that alternative forms o f  the COWA will likely produce similar 
scores.
Gordon Diagnostic System (GDS). The Gordon Diagnostic System (GDS; 
Gordon, 1988) is a measure o f sustained attention and impulse inhibition. Previous 
research indicates that the GDS is a clinically relevant and sensitive tool in the
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assessment o f  ADHD (Mayes, Calhoun, & Crowell, 2001). The GDS is composed o f  two 
tasks. The Delay task measures one’s level o f  behavioral suppression and impulsivity 
while the Vigilance task assesses an individual’s level o f alertness, arousal, and 
impulsivity. On the Delay task, participants are asked to score as many points as possible 
by pressing a button and then delaying and pressing again. If  a subject presses the button 
prematurely, then the individual will not earn a point (correct response) and the timer will 
reset. The amount o f  time required before a correct response is possible remains set 
throughout the task. The measure o f interest was the ratio between correct responses and 
total responses. The Vigilance task requires a participant to respond, as numbers are 
flashed, when a “9” is presented and preceded by a “ 1.” The measures o f  interest were the 
number o f correct responses and the number o f  commission errors.
Stroop Neuropsychological Screening Test (SNST). The Stroop (Trenerry, 
Crosson, DeBoe, & Leber, 1989) is a measure o f inhibitory control and response 
interference. The Stroop was designed to differentiate individuals with organic cerebral 
dysfunction, especially those with left frontal cerebral involvement, from normal 
individuals. There have been multiple variations developed, all o f which are based on the 
same basic paradigm (Van der Elst, Van Boxtel, Van Breukelen, & Jolles, 2006).
Initially, in the Color task individuals are asked to read a list o f color names. These color 
names are not printed in their matching colors. In the Color-Word Task, participants are 
then asked to name the ink color o f words printed in incongruous ink. Although there are 
multiple scoring methods used, a common scoring method involves determining the 
difference in completion time o f the two presented trials (MacLeod, 1991).
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The Stroop has exhibited a test-retest reliability o f .90 and has been found to 
differentiate approximately 79% o f organically-impaired adults from normal adults. The 
Stroop test has been found to exhibit reasonable validity (MacLeod, 1991). Alvarez and 
Emory (2006) concluded that Stroop tests are sensitive to damage in specific regions o f 
the frontal lobes, specifically the lateral and superior medial areas. In the present study, 
the SNST was used to estimate response inhibition and the effects o f interference on 
reaction time, and the variable o f interest was score based on the number o f  correct 
responses provided within 120 seconds.
Tower o f London (ToL). The ToL (Shallice, 1982) was designed to measure 
executive planning and problem-solving abilities in individuals with frontal lobe damage. 
In this task, rods o f  differing heights are presented containing balls o f  differing colors. 
Participants are asked to transition from a start state to a goal state within a specified 
number o f  moves and by following particular rules, such as only moving one ball at a 
time. Several cognitive processes have been related to the ToL task, including visuo- 
spatial working memory, fluid intelligence, and active verbal rehearsal, and it appears to 
be measuring an independent construct (Unterrainer et al., 2004). Additionally, this test 
has been found to be sensitive to individuals with left anterior frontal lobe lesions, as 
these patients make significantly more errors and exhibit longer planning times compared 
to control group members (Shallice, 1982). Numerous forms o f the test have been 
developed with internal consistency, test-retest, and split-half reliabilities being described 
as satisfactory and acceptable (Kaller, Unterrainer, & Stahl, 2012; Schnirman, Welsh, & 
Retzlaff, 1998).
The computerized Sanzen Tower o f  London test (Sanzen Neuropsychological 
Assessment Tests, 2012), which is based on the original design o f  Shallice (1982) and 
provides age-stratified normative data, was used in the current study as a primary 
measure o f planning ability. The variables measured were total number o f  excess moves 
and preplanning time before initial move is performed.
Procedure
Participants were recruited during the intake process o f a residential substance 
abuse treatment facility. Within seven days o f arrival, potential participants were 
approached by the researchers and asked if  they would be willing to volunteer to take part 
in a multi-stage research project for which no compensation was offered. They were 
explicitly informed that participation in this project would have no impact on their 
treatment status. After informed consent was provided by potential participants, then an 
initial questionnaire with the demographic questionnaire, AUDIT, SIP-D, and BDEFS 
were incorporated into the standard battery o f scales and surveys administered to all 
incoming patients. If the standard battery o f  measures was completed before participants 
were recruited, then this initial research questionnaire was administered independently. A 
screening process was utilized in order to identify potential participants who exhibited 
active psychotic symptoms or whose initial treatment plan indicated that the residential 
treatment program would not be fully completed. This screening included consultation 
with the patient’s primary counselor and a review o f the patient’s record and treatment 
plan by a member o f  the treatment staff who is also a part o f  the research team. Such 
clients were included in this study.
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The BAT-37, WASI, CTMT, and Stroop are given to all evaluation cases at this 
facility and this existing data was used by the researchers when available and after 
consent was provided. The study questionnaires were administered before the 
neurocognitive functioning measures were presented. The LNS and COWA were 
administered by one o f the study researchers, in that order. The participants then 
completed a brief battery o f  computerized tests; first the GDS and then the ToL. The 
neuropsychological scales were administered within seven days o f  admission and this 
initial assessment (including the questionnaires and neuropsychological measures) took 
approximately 70 minutes to complete. All scales (other than the WASI, AUDIT, and 
SIP-D) were again administered in the same sequence to all available participants 
approximately 45 days after intake. This assessment took approximately 80 minutes to 
complete.
Data Analyses
Hypothesis One states that neuropsychological measures (LNS, COWA, SNST, 
CTMT, ToL, and GDS) will be negatively associated with self-report measure o f  EF 
domains (BDEFS EF Summary, Self-Management to Time, Self-Organization/Problem- 
Solving, Self-Restraint, Self-Motivation, and Self-Regulation o f Emotions). In order to 
examine this hypothesis, bivariate regression analyses were conducted to estimate the 
level the relationships between self-report EF scores and variables measuring sustained 
attention, verbal fluency, working memory, planning ability, set-shifting ability, and 
response inhibition.
Hypothesis Two states that participants will exhibit lower scores on multiple 
neuropsychological measures compared to established norms for each test. In order to test
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this hypothesis, a series o f  one-sample /-tests were performed for the scores on the, 
CTMT, LNS, SNST, ToL, COWA, and BDEFS and subscales.
Hypothesis Three states study participants will demonstrate significant 
improvements at follow-up on LNS, COWA, CTMT, SNST, and BDEFS scores. 
Significant changes are not expected on to the ToL and GDS tasks. To test this 
hypothesis, a series o f  dependent samples /-tests were utilized to examine differences 
between initial and follow-up scores for participants on neuropsychological measures 
(LNS, COWA, CTMT, SNST, ToL, and GDS) and self-report measure o f EF deficits 
(BDEFS). Investigators initially planned to utilize days o f  abstinence prior to initial 
evaluation as a covariate within a series o f  ANCOVA procedures. However, the number 
o f clean days before testing was not found to be related to performance on any o f  the 
administered measures, thus a dependent samples /-tests were conducted.
Hypothesis Four states that cognitive and EF abilities (both measured by 
performance and self-report methods) will be negatively associated with duration o f 
substance use, substance-related problems, and problematic personality traits. In order to 
test Hypothesis Four, four multiple regression analyses were conducted to identify 
significant predictors o f  years o f substance use, substance-related problems (AUDIT and 
SIP-D scores), and problematic personality traits (BAT-37 scores) among 
neuropsychological assessments (LNS, COWA, CTMT, SNST, GDS, and ToL) and self- 
report problems (BDEFS).
Hypothesis Five states that neurocognitive functioning at intake will be related to 
treatment progression. In order to examine Hypothesis Five, binary logistic regression 
analysis was performed to identify significant predictors (independent variables) o f
treatment retention among the measured executive cognitive functions (GDS, CTMT, 
LNS, SNST, ToL, COWA, and BDEFS). This binary logistic regression analysis 
included initial testing scores. The dependent variable to be predicted was treatment 
retention at time o f  follow-up testing. Lastly, because o f  the number o f statistical 
analyses being performed in this study, Bonferroni correction procedures were applied to 
the statistical tests utilized for the five hypotheses investigated in order to control for 
inflated type 1 error.
CHAPTER THREE
RESULTS
The purpose o f  this study was to examine executive functioning abilities o f 
individuals participating in residential substance abuse treatment and assess any 
alterations in functioning during treatment progression. EF and cognitive abilities were 
assessed using the LNS, COWA, GDS, ToL, Stroop, CTMT, and BDEFS. The following 
chapter presents the results o f the study. Firstly, sample statistics, including means, 
standard deviations, and correlation coefficients, are presented. Results o f  a series o f  one- 
sample /-tests and dependent samples /-tests comparing tests scores to norms and initial 
scores to follow-up scores are discussed. Additionally, multiple regression analyses were 
conducted in order to consider relationships between EF measures and years o f substance 
usage, level o f  problems related to substance usage, and problematic personality 
characteristics. Finally, logistic regression analysis was utilized to order to consider 
predictors o f treatment retention.
Descriptive Statistics
Participants consisted o f  individuals receiving treatment at a private, residential 
substance abuse treatment center. The participants consisted o f  20 males and 20 females 
with their ages ranging from 19 to 60 years o f age with a mean age o f 37.4 (SD = 10.50). 
The sample was composed o f 38 Caucasian Americans (95%) and 2 African-Americans 
(5%), with 60% o f these individuals possessing a college degree and a further 27.5%
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having some college experience. The mean number o f days reported without substance 
use before initial testing occurred was 14.92 (SD = 9.57) with the range being 1 to 42 
days.
In addition, 45% o f the sample indicated that primary motivation for treatment 
concerned being tired o f  current situation and wanting to make life changes. A further 
25% reported seeking treatment in order to maintain their current work status. The most 
frequently reported drugs o f  choice for the present study were alcohol (32.5%), 
opiates/analgesics (30%), and amphetamines (15%), with 5 participants reporting 2 drug 
types. Complete demographic information o f the study sample is presented in Table 1.
















Tired o f Situation 18 45.0
Family Pressure 5 12.5
Legally Ordered 4 10.0
Job-Related 10 25.0
Other 1 2.5
Table 2 displays descriptive statistics o f the initial scores on measures o f 
substance use problems (AUDIT and SIP-D), executive cognitive functioning (LNS,
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COWA, CTMT, SNST, GDS, ToL, WASI and BDEFS), and problematic personality 
characteristics (BAT-37). The means, standard deviations, minimum scores, and 
maximum scores o f  study variables at the initial testing are presented.
Table 2. Descriptive Statistics o f  Initial Testing
Variable N Mean SD Minimum Maximum
AUDIT 38 12.74 12.35 0 35
SIP-D 38 30.21 10.59 1 45
BAT-37 38 9.97 7.48 0 31
BDEFS-T 38 195.34 61.22 94 344
BD EFS-1 38 48.29 18.13 10 84
BDEFS-2 38 50.32 18.44 26 91
BDEFS-3 38 43.55 14.49 20 76
BDEFS-4 38 22.76 9.53 12 48
BDEFS-5 38 29.63 10.89 14 52
BDEFS-SC 38 30.61 25.92 0 86
LNS 40 9.45 1.93 5 14
COWA 40 40.30 13.35 14 69
SNST 35 99.51 15.22 49 112
CTMT 37 41.35 9.67 17 59
GDS-1 39 0.79 0.13 0.30 1
GDS-2 39 42.85 5.09 15 45
GDS-3 39 2.26 4.09 0 12
ToL-1 37 8.76 8.72 0 46
ToL-2 37 6.88 2.06 3.45 13.53
WASI-1 16 106.75 7.66 92 117
WASI-2 16 108.50 9.416 94 130
WASI-3 16 104.06 7.75 87 114
AUDIT = Alcohol Use Disorders Identification Test; SIP-D = Short Index o f Problems- 
Drugs; BAT-37 = Brief Assessment o f Traits -  37; BDEFS-T = Barkley Deficits in 
Executive Functioning Scale-Total EF Summary Score; BDEFS-1 -  BDEFS Self- 
Management to Time; BDEFS-2 = BDEFS Self-Organization/Problem-Solving; BDEFS- 
3 = BDEFS Self-Restraint; BDEFS-4 = BDEFS Self-Motivation; BDEFS-5 = Self- 
Regulation o f  Emotions; BDEFS-SC = BDEFS Symptom Count; LNS = Letter-Number 
Sequencing Standard Score; COWA = Controlled Oral Word Association Test; SNST = 
Stroop Neuropsychological Screening Test; CTMT = Comprehensive Trail-Making Task 
Composite /-Score; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance 
Total Correct; GDS-3 = Vigilance Total CommissionsToL-1 = Tower o f London Task- 
Excess Moves; ToL-2 = Time to First Move WASI-1 = Wechsler Abbreviated Scale o f 
Intelligence Full-Scale IQ; WASI-2 -  Verbal IQ; WASI-3 = Performance IQ; N = 
number o f  participants; SD = Standard Deviation.
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Table 3 consists o f results o f  neuropsychological measures, self-report EF 
problems, and problematic personality characteristics at follow-up testing. The means, 
standard deviations, minimum scores, and maximum scores for the measures o f sustained 
attention, verbal fluency, working memory, planning ability, set-shifting ability, response 
inhibition, self-report EF problems, and problematic personality characteristics are 
displayed.
Table 3. Descriptive Statistics o f  Follow-Up Testing
Variable N Mean SD Minimum Maximum
BAT-37 20 7.65 6.21 0 23
BDEFS-T 20 161.60 54.77 95 312
BDEFS-1 20 38.10 15.27 21 75
BDEFS-2 20 44.95 16.55 25 84
BDEFS-3 20 36.00 11.03 22 65
BDEFS-4 20 18.65 8.62 12 43
BDEFS-5 20 23.90 8.10 13 45
BDEFS-SC 20 17.65 22.24 0 80
LNS 21 10.24 2.05 8 16
COWA 21 43.95 10.89 28 61
SNST 21 108.57 6.23 86 112
CTMT 21 49.10 11.30 33 79
GDS-1 21 0.869 0.093 0.53 1
GDS-2 21 43.71 2.05 38 45
GDS-3 21 .62 .74 0 22
ToL-1 18 6.00 3.24 1 12
ToL-2 18 5.29 1.35 3.56 8.97
BAT-37 = B rief Assessment o f  Traits -  37; BDEFS-T = Barkley Deficits in Executive 
Functioning Scale-Total EF Summary Score; BDEFS-1 = BDEFS Self-Management to 
Time; BDEFS-2 -  BDEFS Self-Organization/Problem-Solving; BDEFS-3 = BDEFS 
Self-Restraint; BDEFS-4 = BDEFS Self-Motivation; BDEFS-5 = Self-Regulation o f 
Emotions; BDEFS-SC = BDEFS Symptom Count; LNS = Letter-Number Sequencing 
Standard Score; COWA = Controlled Oral Word Association Test; SNST = Stroop 
Neuropsychological Screening Test; CTMT = Comprehensive Trail-Making Task 
Composite /-Score; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance 
Total Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f  London Task- 
Excess Moves; ToL-2 = Time to First Move; N  = number o f participants; SD = Standard 
Deviation.
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Further, a series o f  one-way ANOVAs were conducted in order to identify any 
initial differences between genders on study variables, including measures o f EF and 
problematic personality characteristics. No significant differences between males and 
females were found for any o f the neuropsychological tasks administered, and there was 
no difference based on gender on the measure o f  problematic personality characteristics 
utilized. In addition, across the five subscales, EF symptom count, and summary scores 
o f the BDEFS, only one significant difference was found. On average, female 
participants reported significantly more problems with self-organization and problem­
solving abilities when compared to male subjects, F (1 , 36) = 8.627, p = .006, d  = .95, 
with a large effect size.
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Table 4. Differences between Genders across Study Variables
Variable Males Mean (SD) Females Mean (SD) F P
AUDIT 15.00(12.70) 10.47(11.90) 1.285 .264
SIP-D 29.11 (11.72) 31.32 (9.53) .407 .528
BAT-37 8.68 (6.92) 11.26 (7.97) 1.134 .294
BDEFS-T 176.79 (49.39) 213.89(67.36) 3.750 .061
BDEFS-1 46.63 (14.86) 49.95 (21.19) .312 .580
BDEFS-2 42.32(11.85) 58.32 (20.58) 8.627 .006**
BDEFS-3 39.74(13.11) 47.37(15.13) 2.763 .105
BDEFS-4 21.00 (7.67) 24.53 (11.02) 1.311 .260
BDEFS-5 27.11 (10.98) 32.16(10.47) 2.107 .155
BDEFS-SC 24.37 (22.26) 36.84 (28.34) 2.276 .140
LNS 9.60(1.82) 9.30 (2.08) .236 .630
COWA 42.50 (14.87) 38.10(11.60) 1.088 .303
SNST 101.28(16.67) 96.79(13.53) .812 .374
CTMT 42.00 (7.47) 40.74(11.56) .154 .697
GDS-1 .78 (.10) .80 (.15) .310 .581
GDS-2 42.11 (6.67) 43.55 (2.95) .623 .435
GDS-3 2.79 (4.88) 1.75 (3.21) .780 .383
ToL-1 8.50 (9.90) 9.06 (7.37) .037 .849
ToL-2 7.31 12.21) 6 .37(1.80) 1.955 .171
AUDIT = Alcohol Use Disorders Identification Test; SIP-D = Short Index o f  Problems- 
Drugs; BAT-37 = Brief Assessment o f Traits -  37; BDEFS-T = Barkley Deficits in 
Executive Functioning Scale-Total EF Summary Score; BDEFS-1 = BDEFS Self- 
Management to Time; BDEFS-2 = BDEFS Self-Organization/Problem-Solving; BDEFS- 
3 = BDEFS Self-Restraint; BDEFS-4 = BDEFS Self-Motivation; BDEFS-5 = Self- 
Regulation o f  Emotions; BDEFS-SC = BDEFS Symptom Count; LNS = Letter-Number 
Sequencing Standard Score; COWA = Controlled Oral Word Association Test; SNST = 
Stroop Neuropsychological Screening Test; CTM T = Comprehensive Trail-Making Task 
Composite f-Score; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance 
Total Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f  London Task- 
Excess Moves; ToL-2 = Time to First Move; *p < .05 **p < .01.
Correlations between Neuropsychological
Variables
Table 5 displays Pearson correlation coefficients between initial scores on the 
administered neuropsychological tests (LNS, COWA, CTMT, SNST, ToL, GDS, and 
WASI). Multiple correlations were found to be significant, including the relationship 
between set-shifting ability (CTMT) and response inhibition (SNST) which was r(37) = 
.555, p  -  .000. In addition, a significant positive correlation, r(40) = .529, p  = .000, was
found between measure o f working memory (LNS) and verbal fluency (COWA ), while a 
significant, and negative, relationship was found between a measure o f  planning ability 
(ToL excessive moves) and sustained attention (GDS Vigilance total correct score), r(36) 
= -.666, p  = .000. Moreover, the WASI-FSIQ was not found to be significantly associated 
with any other cognitive measure. In addition, the average time to first move o f the ToL 
was also not significantly related to any other measures administered at initial testing.
Table 5. Correlation Matrix o f  Neuropsychological Variables




4-SNST .279 .077 .555**
5-GDS-l .321* -.007 .025 .132
6-GDS-2 .358* .112 .468** .654** .367*
7-GDS-3 -.366* -.047 -.485** -.640** -.377* -.950**
8-ToL-l -.165 -.040 -.414** -.519** -.102 -.666** .610**
9-ToL-2 -.110 -.053 -.127 .166 -.023 .154 -.121 -.183
10-WASI -.069 .401 .512 .232 -.205 -.126 .059 -.090 .210
LNS = Letter-Number Sequencing Standard Score; COWA = Controlled Oral Word 
Association Test; SNST = Stroop Neuropsychological Screening Test; CTMT ;= 
Comprehensive Trail-Making Task Composite /-Score; GDS-1 = Gordon Diagnostic 
System Delay ER; GDS-2 = Vigilance Total Correct; GDS-3 = Vigilance Total 
Commissions; ToL-1 = Tower o f London Task-Excess Moves; ToL-2 = Time to First 
Move; WASI = Wechsler Abbreviated Scale o f Intelligence Full-Scale IQ; *p < .05 **p < 
.0 1 .
Results for Hypotheses
Hypothesis One. Hypothesis One states that self-report measure o f EF (BDEFS 
and subscales) will be related to scores on performance measures o f  cognitive abilities 
(LNS, COWA, GDS, SNST, CTMT, and ToL) at initial testing. In order to assess 
Hypothesis One, Pearson correlations were conducted to examine the relationships 
between BDEFS scores (subscales and total EF Summary scores) and scores on the LNS, 
COWA, SNST, CTMT, GDS, and ToL at initial testing. Due to the number o f tests being
62
conducted, Bonferroni correction was applied to these series o f  correlation coefficients 
with an adjustedp -value o fp  =.006.
Results o f  the analyses identified no cognitive ability was significantly related to 
BDEFS scores at intake, after applying a Bonferroni correction. The strongest correlation 
found, although not significant, was between the GDS Vigilance Task Total Correct score 
and BDEFS Total EF Summary score r(37) = -.405,/? = .013 indicating that higher 
vigilance scores may be related to fewer reported EF deficits. These findings are 
inconsistent with the hypothesized results. Table 6 presents the Pearson correlation 
coefficients.
Table 6. Pearson Correlations between BDEFS Total EF Summary Score and Cognitive
Functioning Measures at Initial Testing
Cognitive Measures N r P
LNS 38 .056 .738
COWA 38 -.090 .590
SNST 35 -.147 .401
CTMT 35 -.203 .242
GDS-1 37 -.069 .685
GDS-2 37 -.405 .013*
GDS-3 37 .298 .073
ToL-1 35 -.100 .566
ToL-2 35 .012 .944
BDEFS = Barkley Deficits in Executive Functioning Scale-Total EF Summary Score; 
LNS = Letter-Number Sequencing; COWA = Controlled Oral Word Association Test; 
SNST = Stroop Neuropsychological Screening Test; CTMT = Comprehensive Trail-
Making Task; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance Total 
Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f London-Excess 
Moves; ToL-2 = Time to First Move; N = number o f participants; R = Pearson 
correlation value; P -  probability; *p < .05 **p < .006 (Bonferroni-corrected /?-value).
Results identified no significant relationships between the BDEFS Self- 
Management to Time subscale and executive functioning variables, after applying a 
Bonferroni correction. Again, the strongest nonsignificant correlation was between the
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Self-M anagement to Time subscale and the Vigilance Task Total Correct score, r(37) = 
-390,  p  = .017. Table 7 presents the Pearson correlation coefficients.
Table 7. Pearson Correlations between BDEFS Self-Management to Time Subscale and 
Cognitive Functioning Measures at Initial Testing
Cognitive Measures N r P
LNS 38 .097 .561
COWA 38 -.043 .799
SNST 35 .106 .545
CTMT 35 -.133 .445
GDS-1 37 -.233 .164
GDS-2 37 -.390 .017*
GDS-3 37 .298 .074
ToL-1 35 -.233 .179
ToL-2 35 .119 .494
BDEFS = Barkley Deficits in Executive Functioning Scale-Total EF Summary Score; 
LNS = Letter-Number Sequencing; COWA = Controlled Oral Word Association Test; 
SNST = Stroop Neuropsychological Screening Test; CTMT = Comprehensive Trail- 
Making Task; GDS-1 -  Gordon Diagnostic System Delay ER; GDS-2 = Vigilance Total 
Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f London-Excess 
Moves; ToL-2 = Time to First Move; N = number o f participants; R = Pearson 
correlation value; P = probability; *p < .05 **p < .006 (Bonferroni-corrected p - value).
After applying a Bonferroni correction, no significant relationships were found 
between the BDEFS Self-Organization/Problem-Solving subscale and any o f the 
neuropsychological measures administered at initial testing. The strongest nonsignificant 
correlation was between the Vigilance Task Total Correct score and self-report 
organizational problems, r(37) = -.259, p  = .029. Table 8 presents the Pearson correlation
coefficients.
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Table 8. Pearson Correlations between BDEFS Self-Organization/Problem-Solving
Subscale and Cognitive Functioning Measures at Initial Testing
Cognitive Measures N r P
LNS 38 .066 .692
COWA 38 -.069 .680
SNST 35 -.181 .299
CTMT 35 -.175 .316
GDS-1 37 -.113 .507
GDS-2 37 -.259 .029*
GDS-3 37 .230 .170
ToL-1 35 .037 .832
ToL-2 35 -.246 .154
BDEFS = Barkley Deficits in Executive Functioning Scale-Total EF Summary Score; 
LNS = Letter-Number Sequencing; COWA = Controlled Oral Word Association Test; 
SNST = Stroop Neuropsychological Screening Test; CTM T = Comprehensive Trail- 
Making Task; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance Total 
Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f  London-Excess 
Moves; ToL-2 = Time to First Move; N = number o f  participants; R = Pearson 
correlation value; P = probability; *p < .05 *p < .05 **p < .006 (Bonferroni-correctedp-  
value).
Results identified no significant relationships between the BDEFS Self-Restraint 
subscale and any o f the neuropsychological measures administered at initial testing. 
Table 9 presents the Pearson correlation coefficients.
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Table 9. Pearson Correlations between BDEFS Self-Restraint Subscale and Cognitive
Functioning Measures at Initial Testing
Cognitive Measures N r P
LNS 38 .047 .777
COWA 38 -.100 .549
SNST 35 -.186 .286
CTMT 35 -.194 .263
GDS-1 37 .103 .543
GDS-2 37 -.257 .124
GDS-3 37 .205 .224
ToL-1 35 -.055 .755
ToL-2 35 .112 .521
BDEFS = Barkley Deficits in Executive Functioning Scale-Total EF Summary Score; 
LNS = Letter-Number Sequencing; COWA = Controlled Oral Word Association Test; 
SNST = Stroop Neuropsychological Screening Test; CTM T = Comprehensive Trail- 
Making Task; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance Total 
Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f  London-Excess 
Moves; ToL-2 = Time to First Move; N = number o f participants; R = Pearson 
correlation value; P = probability; *p < .05 **p < .006 (Bonferroni-corrected p-value).
The BDEFS Self-Motivation subscale was found to be negatively correlated to 
one neuropsychological measure, the Vigilance Task Total Correct, r(37) = -.474,/? = 
.003, after applying a Bonferroni correction. Findings suggest that better vigilance 
abilities, and reduced impulsivity, are related to fewer problems with self-motivation and 
level o f  work effort. Table 10 presents the Pearson correlation coefficients.
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Table 10. Pearson Correlations between BDEFS Self-Motivation Subscale and Cognitive
Functioning Measures at Initial Testing
Coenitive Measures N r P
LNS 38 .059 .724
COWA 38 -.037 .827
SNST 35 -.161 .357
CTMT 35 -.151 .387
GDS-1 37 -.099 .559
GDS-2 37 -.474 .003*
GDS-3 37 .316 .057
ToL-1 35 -.221 .202
ToL-2 35 .034 .845
BDEFS = Barkley Deficits in Executive Functioning Scale-Total EF Summary Score; 
LNS = Letter-Number Sequencing; COWA = Controlled Oral Word Association Test; 
SNST = Stroop Neuropsychological Screening Test; CTMT = Comprehensive Trail- 
Making Task; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance Total 
Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f  London-Excess 
Moves; ToL-2 = Time to First Move; N = number o f  participants; R = Pearson 
correlation value; P = probability; *p < .05 **p < .006 (Bonferroni-correctedp - value).
Results identified no significant relationships between the BDEFS Self-
Regulation o f Emotions subscale and the neuropsychological measures administered at
initial testing after applying a Bonferroni Correction. Table 11 presents the Pearson
correlation coefficients.
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Table 11. Pearson Correlations between BDEFS Self-Regulation o f  Emotions Subscale
and Cognitive Functioning Measures at Initial Testing
Cognitive Measures N r P
LNS 38 -.056 .739
COWA 38 -.153 .361
SNST 35 -.206 .236
CTMT 35 -.121 .490
GDS-1 37 .074 .663
GDS-2 37 -.326 .049*
GDS-3 37 .277 .098
ToL-1 35 -.009 .958
ToL-2 35 .074 .671
BDEFS = Barkley Deficits in Executive Functioning Scale-Total EF Summary Score; 
LNS = Letter-Number Sequencing; COWA = Controlled Oral Word Association Test; 
SNST = Stroop Neuropsychological Screening Test; CTMT = Comprehensive Trail- 
Making Task; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance Total 
Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f  London-Excess 
Moves; ToL-2 = Time to First Move; N = number o f  participants; R = Pearson 
correlation value; P = probability; *p < .05 **p<  .006 (Bonferroni-correctedp - value).
Hypothesis Two. Hypothesis Two states that participants will exhibit lower 
scores on multiple neuropsychological measures compared to established norms for each 
scale. In order to test this hypothesis, a series o f  one-sample /-tests were performed for 
the initial scores on the CTMT, LNS, SNST, ToL, COWA, and BDEFS, and these 
analyses had a Bonferroni correction applied resulting in an adjusted /?-value to test for 
significance o f  .004.
The BDEFS was utilized as a self-report measure o f multiple executive functions 
across five subscales, a summary score, and an EF symptom count. Initial EF Summary 
scores o f the BDEFS for the study participants were found to be significantly different 
from the norm group with participants reporting higher levels o f  EF deficits (M  = 195.34, 
SD = 61.22) than the normative sample (Barkley, 2011; M  = 133.90). This significant 
difference, /(37) = 6.187,/? = .000, represents a large effect size, r = .72. Further, 
participants reported a significantly higher number o f EF symptoms (M  = 30.61,
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SD = 25.92) when compared to a norm group (M =  7.31), /(37) = 5.541 ,/? = .000, with a 
large effect size, r = .67.
In addition, study participants, on average, reported more problems with self­
organizing skills (M  = 48.29, SD = 18.13) than the normative group (M  -  35.99) at initial 
testing. This difference was found to be significant and represents a moderate to large 
effect size, /(37) = 4.182,/? = .000, r = .56. Participants also endorsed significantly more 
time management problems (M  = 50.32, SD = 18.40) when compared to the norm group 
(M = 34.30), /(37) = 5.354,/? = .000, with a large effect size, r -  .66. In terms o f 
perceived self-restraint, the normative sample reported fewer problems (M =  28.47) than 
study sample (M  = 43.55, SD = 14.49), and this difference is statistically significant, 
t{37) = 6.419,/? = .000, and represents a large effect size, r = .73.
Moreover, at initial testing, participants endorsed a higher number o f problems 
with emotional regulation (.M = 22.76, SD  = 9.53) when compared to the normative 
sample ( M -  19.38). This difference was found to be statistically significant with a 
moderate effect size, /(37) = 2.188,/? = .035, r = .34. Finally, a higher level o f problems 
with self-motivation and effort in work was reported by participants (M  = 29.63, SD  = 
10.89) compared to the normative sample (M =  15.37). The observed difference was 
found to be significant and shows a large effect size, /(37) = 8.074, p  = .000, r = .80. 
These significant differences were consistent with predicted self-report deficits o f  the 
substance-abusing sample participants.
Initial scores o f the CTMT, a measure o f  set-shifting and divided attention, were 
found to be significantly different from the mean o f the norm group and this discrepancy 
supports the stated hypothesis. On average, study participants spent more time
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(composite /-score M  = 41.35, SD  = 9.67) completing the trail-making tasks compared to 
the norm group (composite /-score M  -  50, SD = 10). This difference was found to be 
significant, /(36) = -5.44, p  = .000, and represents a large effect size, r = 0.67.
The SNST was utilized to examine interference effects, response inhibition, and 
possible brain damage among study participants. Initial SNST scores o f  the participants 
(M  = 98.97, SD = 15.10) were found to be, on average, lower than norm group scores 
(Trenerry et al., 1989; M  = 104.90, SD  = 10.22). However, after applying a Bonferroni 
correction, this difference was not found to be significant, /(36) = -2.388, p  = .022, but 
does represent a moderate effect size, r = 0.37. Results did not support the stated 
hypothesis. Further, 14 participants fell below the identified cut-off score o f  99, 
indicating these individuals would be designated in the brain-damaged range.
Scores o f  the ToL, a measure o f  planning ability and problem-solving, produced 
two variables o f  interest, number o f  excessive moves needed to complete trials and time 
spent before making first move across all 21 trials. There was found to be no significant 
difference between study participants’ initial average number o f  excess moves across all 
trials {M  = 8.76, SD  = 8.76) compared to the norm group (M  = 8.5), /(36) = . 179, p  = 
.859, with a small effect size, r  = 0.10. Further, there was no significant difference 
between participants (M = 6.88, SD -  2.06) and the Tower o f  London norm group (M = 
6.575, SD = 3.93) for average time before first move across all trials, /(36) = .902, p  = 
.373, with a small effect size, r  = 0.14. These results do not provide support for the 
hypothesis.
The measure o f  verbal fluency and communication deficits, COWA, produced 
two variables o f  interest, total number o f words produced across three letters (FAS) and
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total number o f  animals named within 60 seconds. On average, study participants 
produced fewer words (M  = 40.30, SD = 13.35) compared to reported metanorms based 
on education level (M  = 41.14, SD = 12.37; Loonstra, Tarlow, & Sellers, 2001), /(39) = - 
.398, p  = .693, r -  0.06. However, this difference was not found to be significant. Further, 
there was no significant difference between study participants production o f animal 
names (M  = 21.95, SD  = 5.1) and norm group performance (M  = 21.9 ,S D  = 5.4), t(39) = 
.062, p  = .951. These differences do not support hypothesis.
The LNS task was utilized to measure working memory and attentional abilities. 
Study participants produced lower scores on the LNS task (Af = 9.45, SD = 1.93) 
compared to norm group mean standard score (M =  10, SD = 3). However, this difference 
was not found to be significant, /(39) = -1.798, p  = .08, with a small effect size, r = 0.28, 
and did not support hypothesis.
Moreover, Table 12 presents information on the differences between the study 
sample and normative samples across measures.
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Table 12. Differences between Study Sample and Normative Samples across Variables
Variable Initial M Normative M t P 1.5 SD (Perc)
BDEFS-T 195.34 133.90 6.187 .000**
BDEFS-1 50.32 34.30 5.354 .000**
BDEFS-2 48.29 35.99 4.182 .000**
BDEFS-3 43.55 28.47 6.419 .000**
BDEFS-4 29.63 15.37 8.074 .000**
BDEFS-5 22.76 19.38 2.188 .035*
BDEFS-SC 30.61 7.31 5.541 .000**
LNS 9.45 10.0 -1.798 .080 2 (5.00)
COWA 40.30 41.14 -.398 .693 6(15.00)
SNST 98.97 104.90 -2.238 .022* 8(22.86)
CTMT 41.35 50.0 -5.44 .000** 10(27.02)
ToL-1 8.76 8.5 .179 .859
ToL-2 6.88 6.575 .902 .373 ..... 3(8 .12)
BDEFS-T = Barkley Deficits in Executive Functioning Scale-Total EF Summary Score; 
BDEFS-1 = BDEFS Self-Management to Time; BDEFS-2 = BDEFS Self-
Organization/Problem-Solving; BDEFS-3 = BDEFS Self-Restraint; BDEFS-4 = BDEFS 
Self-Motivation; BDEFS-5 = Self-Regulation o f  Emotions; BDEFS-SC = BDEFS 
Symptom Count; LNS = Letter-Number Sequencing Standard Score; COWA = 
Controlled Oral Word Association Test; SNST = Stroop Neuropsychological Screening 
Test; CTMT = Comprehensive Trail-Making Task Composite /-Score; ToL-1 = Tower o f 
London Task-Excess Moves; ToL-2 = Time to First Move; 1.5 SD (Perc) = Number and 
Percentage o f Scores 1.5 SD Below Mean; * p  < .05 **p < .004 (Bonferroni-corrected p- 
value).
Finally, the GDS was utilized as a measure o f  sustained attention and impulsivity. 
This diagnostic tool consists o f two tasks (Delay and Vigilance) with three measures o f 
interest for which scores are classified into o f  three ranges (normal, borderline, and 
abnormal). The original normative sample statistics were unavailable for this study but 
the number o f  scores falling within diagnostic ranges are provided. For the Delay Task 
E.R. score, 4 individuals fell in the abnormal range, 18 in the borderline range, and 17 in 
the normal range. For the total correct scores on the Vigilance Task, 2 participants scored 
in the abnormal range, 6 in the borderline range, and 31 in the normal range. Finally, for 
the Vigilance Task total commission errors, 2 individuals fell into the abnormal range, 4
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fell into the borderline range, and 33 in the normal range. Table 13 presents information 
on the distribution o f  GDS scores.














Hypothesis Three. Hypothesis Three states that participants would demonstrate 
significant improvements at follow-up on the LNS, COWA, CTMT, SNST, and BDEFS 
scores. Significant changes were not expected on the ToL and GDS tasks. In order to test 
these hypotheses, a series o f dependent /-tests were conducted comparing intake and 
follow-up scores on all neuropsychological measures and self-report measures. To 
control for the number o f  tests performed a Bonferroni correction was applied, and an 
adjusted /?-value, .003 was utilized. Table 14 presents results o f this series o f dependent /- 
tests.
Participants exhibited higher scores on the follow-up administration o f  the LNS 
(M =  10.24, SE = .447) compared to the initial scores (M =  10.10, SE = .365). However, 
this difference was not significant, /(20) = .349,/? = .731, r = .08, indicating no clinically- 
relevant changes in auditory working memory performance which does not support stated 
hypothesis. On average, scores on verbal fluency task (COWA) were lower at intake
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(M =  43.33, SE = 2.39) than at follow-up testing (Af = 43.95, SE = 2.38), but, again, this 
difference was not statistically significant, 7(20) = .421, p  = .678, r = .09. Findings do not 
support the study hypothesis.
Further, three variables were examined for the GDS (a measure o f sustained 
attention). After applying a Bonferroni correction, there was no significant difference 
between initial (M  = .80, SE = .03) and follow-up scores (M = .87, SE = .02) for the 
Delay Task, 7(20) = 2.135,/? = .045, r = .43, although a moderate effect size was found.
At follow-up, participants exhibited a higher ability to maintain attention and inhibit 
impulsive responses in order to complete the task. There were no significant differences 
between initial (A /= 1.05, SE = .244; M =  44.10, SE = .22) and follow-up scores {M =
.62, SE = .161; M =  43.71, SE -  .448) for commission errors, 7(20) = -1.910,/? = .071, 
r = .39, or total correct responses, 7(20) = -1.017,/? = .321, r = .24, respectively on the 
Vigilance Task. These results provide support for the hypothesis.
For the SNST, a measure o f  inhibitory control/response inhibition, participants 
exhibited significantly higher scores (M =  108.50, SE = 1.43) at follow-up than at initial 
testing (A/= 102.00, SE = 2.44). This difference was found to be significant with a large 
effect size, /(19) = 3.585, p  = .002, r = .64, and provides support for the hypothesis. In 
addition, study participants scored significantly higher on a measure o f set-shifting, 
CTMT, at follow-up (M  = 49.40, SE = 2.57) than at initial testing (M =  43.20, SE = 1.98), 
/(19) = 3.823,/? = .001, r = .66, with a large effect size, which was hypothesized. These 
results show that participants’ level o f response inhibition and set-shifting ability 
improved significantly during early abstinence and participation in substance abuse 
treatment.
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The two variables o f interest for the measure o f  planning ability, from the ToL 
task, were number o f excess moves and average time to first move. Participants exhibited 
fewer excess moves at follow-up (M =  6.00, SE = .763) than at intake (M = 6.72, SE = 
1.18). This difference was not significant and provided support for the hypothesis, t ( \ l )  = 
-.663, p  = .517, r = .16. However, participants spent significantly less time, on average, 
planning first move at follow-up testing (M =  5.29, S E =  .32) than at initial testing (M  = 
6.65, SE -  .52), /(17) = -3.889, p  = .001, r -  .68, with a large effect size which did not 
support stated hypothesis. These results suggest that participants’ planning ability may 
have become quicker and more efficient after a period o f  abstinence.
Participants self-reported more EF problems at intake (M  = 200.55, SE ~-z 15.54) 
than at follow-up (M =  161.60, S E =  12.25), /(19) = -2.923, p  = .009, r = .56, with a large 
effect size, although this difference was not significant after applying a Bonferroni 
correction. They also reported having more EF symptoms at intake (M =  34.00, SE = 
6.26) than at follow-up testing (M = 17.65, SE = 4.98). However, this Bonferroni- 
corrected difference was not significant, /(19) = -2.922,p -  .009, r = .56, but does 
represent a large effect size. These results do not provide support for the hypothesis.
In addition, participants, on average, endorsed more problems with time 
management (M  = 49.15, SE = 4.53) at intake than at follow-up (M  = 38.10, SE = 3.41). 
This Bonferroni-corrected difference was nonsignificant but did represent a large effect 
size, /(19) = -2.977,p  = .008, r = .56. Study participants also reported more problems 
with self-organization at intake (M  = 54.30, SE = 4.45) than at follow-up ( M =  44.95; SE 
= 3.70). However, this Bonferroni-corrected difference was not significant,
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f(37) = -2.794,/? = .012, but does show a large effect size, r = .54. These results do not 
support the hypothesis.
Moreover, when a Bonferroni correction is utilized, perceived self-restraint 
problems were not significantly higher at intake ( M =  45.30; SE = 3.60) than at follow-up 
( M =  36.00; SE = 2.47), t(19) = -2.917,/? = .009, r -  .56, although a large effect size was 
observed. At initial testing, participants endorsed a higher number o f problems with self- 
motivation and effort in work (M  = 22.60, SE = 2.30) than at follow-up testing (M = 
18.65; SE = 1.93). However, this difference was not found to be statistically significant,
/(19) = -1.757,/? = .095, r = .37. Further, a greater number o f  problems with emotional 
regulation were endorsed by participants at intake (M  = 29.20, SE = 2.58) than at follow- 
up testing (A /= 23.90; SE = 1.81), but the observed difference was not found to be 
significant, /(19) = -1.955, p  = .066, r = .41 but does have a moderate effect size. These 
results do not support the stated hypothesis.
Finally, at initial testing ( M =  10.10; S E=  1.799) participants endorsed a higher 
number o f  problematic personality characteristics than at follow-up (M = 7.65; SE =
1.388). However, this difference was not significant but does show a moderate effect 
size, /(19) = -1.671, p  = A \ \ , r = .  36.
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Table 14. Differences between Initial and Follow-up Scores across Study Variables
Variable Initial Mean (SE) Foliow-Ud Mean (SE) / V
BAT-37 10.10(1.80) 7.65 (1.39) -1.671 .111
BDEFS-T 200.55 (15.54) 161.60(12.25) -2.922 .009*
BDEFS-1 49.15 (4.53) 38.10(3.41) -2.977 .008*
BDEFS-2 54.30 (4.45) 44.95 (3.70) -2.794 .012*
BDEFS-3 45.30(3.60) 36.00 (2.47) -2.917 .009*
BDEFS-4 22.60 (2.30) 18.65 (1.93) -1.757 .095
BDEFS-5 29.20 (2.58) 23.90(1.81) -1.955 .066
BDEFS-SC 34.00 (6.26) 17.65 (4.97) -2.922 .009*
LNS 10.10 (.365) 10.24 (.447) .349 .731
COWA 43.33 (2.39) 43.95 (2.38) .421 .678
SNST 102.00 (2.44) 108.50(1.43) 3.585 .002**
CTMT 43.20(1.98) 49.40 (2.57) 3.823 .001**
GDS-1 .80 (.03) .87 (.02) 2.135 .045*
GDS-2 44.10 (.217) 43.71 (.448) -1.017 .321
GDS-3 1.05 (.244) .62 (.161) -1.910 .071
ToL-1 6.72(1.18) 6.00 (.76) -.663 .517
ToL-2 6.65 (.52) 5.29 (.32) -3.889 .001**
BAT-37 = Brief Assessment o f  Traits -  37; BDEFS-T = Barkley Deficits in Executive 
Functioning Scale-Total EF Summary Score; BDEFS-1 = BDEFS Self-Management to 
Time; BDEFS-2 = BDEFS Self-Organization/Problem-Solving; BDEFS-3 = BDEFS 
Self-Restraint; BDEFS-4 = BDEFS Self-Motivation; BDEFS-5 = Self-Regulation o f 
Emotions; BDEFS-SC = BDEFS Symptom Count; LNS = Letter-Number Sequencing 
Standard Score; COWA = Controlled Oral Word Association Test; SNST = Stroop 
Neuropsychological Screening Test; CTMT = Comprehensive Trail-M aking Task 
Composite /-Score; GDS-1 = Gordon Diagnostic System Delay ER; GDS-2 = Vigilance 
Total Correct; GDS-3 = Vigilance Total Commissions; ToL-1 = Tower o f  London Task- 
Excess Moves; ToL-2 = Time to First Move; * p  < .05 **p < .003 (Bonferroni-corrected 
/7-value).
Hypothesis Four. Hypothesis Four states that EF will be associated with duration 
o f substance use, substance-related problems, and personality characteristics. To test 
Hypothesis Four, four multiple regression analyses were conducted to identify significant 
predictors among executive functions (GDS, LNS, ToL, COWA, SNST, CTMT), and 
self-report problems (BDEFS) for the following dependent variables; years o f substance 
abuse, substance-related problems (AUDIT total and SIP-D total scores), and problematic 
personality traits (BAT-37 total scores). In order to control for the number o f tests
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performed, a Bonferroni correction was used for the following multiple regression 
analyses and the adjusted /?-value utilized to test for significance was .005.
Table 15 summarizes the results o f  the regression predicting SIP-D total score. A 
significant regression model with 10 predictors was found, F (1 0 ,22) = 10.02, p  =.000, 
with an R2-  .82. Among variables examined, BDEFS Total EF Summary score {fi = .88, 
t(32) = 8.34,/? = .000) was the strongest predictor o f self-report substance use problems 
(SIP-D). Higher self-reported EF deficits were predictive o f  more reported substance use 
problems and negative consequences related to drug use. Two additional significant 
predictors were number o f  commission errors (fi = .57, /(32) = 4.42, p  = .004) and total 
correct scores (fi = .43, t(32) = 3.18,/? = .000) on the Vigilance Task o f the GDS 
indicating that more impulsive responses, and reduced visual vigilance, are associated 
with higher levels o f negative drug-related problems. A final significant predictor o f 
adverse consequences was CTMT performance, (/? = -.39, /(32) = -3.48,/? = .000), 
suggesting that set-shifting ability is predictive o f  level o f substance-related problems.
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Table 15. Regression Analysis Predicting SIP-D Scores
Variable B SEB 0 t P
Constant -145.22 51.35
COWA .02 .10 .02 .16 .874
LNS -2.15 .68 -.40 -3.16 .005*
GDS-1 13.23 8.24 .16 1.61 .123
GDS-2 3.55 1.12 .43 3.18 .004**
GDS-3 3.72 .84 .57 4.42 .000**
SNST .21 .09 .23 2.28 .033
CTMT -.48 .14 -.39 -3.48 .002**
ToL-1 -.28 .17 -.17 -1.66 .111
ToL-2 -.53 .52 -.10 -1.02 .317
BDEFS-T .16 .02 .88 8.34 .000**
COWA = Controlled Oral Word Association; LNS = Letter-Number Sequencing 
Standard Score; GDS = Gordon Diagnostic System Delay ER; SNST = Stroop 
Neuropsychological Screening Test; CTMT = Comprehensive Trail-Making Task 
Composite /-Score; GDS-2 = Vigilance Total Correct; GDS-3 = Vigilance Total 
Commissions; ToL-1 = Tower o f  London Task-Excess Moves; ToL-2 = Time to First 
Move; BDEFS-T = Barkley Deficits in Executive Functioning Scale-Total EF Summary 
Score; R2 = .82; *p < .05 **p < .005 (Bonferroni-corrected p-value).
Table 16 displays the results for the regression model predicting AUDIT total 
score. The regression model with 10 predictors was not found to be significant, .F(10, 22) 
= .592, p  =.803, with an R2 -  .21. Overall, no significant predictors for alcohol use and 
related problems were identified among the neuropsychological variables examined in
this study.
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Table 16. Regression Analysis Predicting AUDIT Scores
Variable B SEB 0 / P
Constant 21.64 134.47
COWA .19 .26 .20 .74 .467
LNS -.31 1.78 -.05 -.22 .828
GDS-1 27.43 21.57 .27 1.27 .217
GDS-2 -1.09 2.92 -.11 -.37 .713
GDS-3 -.24 2.20 -.03 -.11 .914
SNST -.03 .24 -.03 -.12 .907
CTMT .01 .36 .01 .01 .990
ToL-1 -.28 .44 -.14 -.63 .534
ToL-2 2.22 1.37 .34 1.63 .118
BDEFS-T .02 .05 .10 .44 .663
COWA = Controlled Oral Word Association; LNS = Letter-Number Sequencing 
Standard Score; GDS = Gordon Diagnostic System Delay ER; SNST = Stroop 
Neuropsychological Screening Test; CTMT = Comprehensive Trail-M aking Task 
Composite /-Score; GDS-2 = Vigilance Total Correct; GDS-3 = Vigilance Total 
Commissions; ToL-1 = Tower o f London Task-Excess Moves; ToL-2 = Time to First 
Move; BDEFS-T = Barkley Deficits in Executive Functioning Scale-Total EF Summary 
Score; R2 = .21; *p < .05 **p < .005 (Bonferroni-correctedp-value).
Table 17 presents the results for the regression model predicting BAT-37 total 
score. The regression model with 10 predictors was found to be significant, F(10, 22) = 
5.17, p  =.000, with an R2-  .72. The only significant predictor among variables for BAT- 
37 scores was BDEFS Total EF Summary score (fi = .82, /(32) = 6.32, p  = .000). Findings 
indicate that a higher level o f self-report EF deficits was related to more identified 
problematic personality traits.
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Table 17. Regression Analysis Predicting BAT-37 Scores
Variable B SEB 0 / P
Constant -101.53 47.16
COWA -.01 .09 -.01 -.07 .947
GDS-1 13.36 7.57 .22 1.77 .091
GDS-2 1.59 1.03 .26 1.55 .136
GDS-3 .60 .77 .12 .78 .446
SNST .19 .09 .28 2.17 .041*
CTMT -.15 .13 -.16 -1.19 .247
ToL-1 -.07 .15 -.05 -.42 .676
ToL-2 -.14 .48 -.04 -.29 .774
BDEFS-T .11 .02 .82 6.32 .000**
COWA = Controlled Oral Word Association; LNS = Letter-Number Sequencing 
Standard Score; GDS = Gordon Diagnostic System Delay ER; SNST = Stroop 
Neuropsychological Screening Test; CTMT = Comprehensive Trail-Making Task 
Composite /-Score; GDS-2 = Vigilance Total Correct; GDS-3 = Vigilance Total 
Commissions; ToL-1 = Tower o f  London Task-Excess Moves; ToL-2 = Time to First 
Move; BDEFS-T = Barkley Deficits in Executive Functioning Scale-Total EF Summary 
Score; R2 = .72; *p < .05 **p < .005 (Bonferroni-corrected /7-value).
Table 18 displays results o f  the multiple regression for predicting years o f 
substance usage. The regression model with 10 predictors was not found to be significant, 
F(10, 21) = .33,/? =.961, with an R2-  .14. No significant predictors for years o f substance 
usage was identified among the neuropsychological measures examined in this study.
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Table 18. Regression Analysis Predicting Years o f  Substance Abuse
Variable B S E B 0 t P
Constant 2.68 124.79
COWA .09 .24 .11 .38 .707
LNS .61 1.65 .10 .37 .717
GDS-1 13.49 20.04 .15 .67 .508
GDS-2 -.49 2.75 -.06 -.18 .860
GDS-3 -.09 2.03 -.01 -.04 .965
SNST -.06 .22 -.06 -.26 .798
CTMT .15 .38 .10 .40 .691
ToL-1 .20 .45 .11 .44 .665
ToL-2 1.96 1.28 .35 1.54 .139
BDEFS-T -.01 .05 -.05 -.22 .832
COWA = Controlled Oral Word Association; LNS = Letter-Number Sequencing 
Standard Score; GDS -  Gordon Diagnostic System Delay ER; SNST = Stroop 
Neuropsychological Screening Test; CTM T = Comprehensive Trail-M aking Task 
Composite /-Score; GDS-2 = Vigilance Total Correct; GDS-3 = Vigilance Total 
Commissions; ToL-1 = Tower o f  London Task-Excess Moves; ToL-2 = Time to First 
Move; BDEFS-T = Barkley Deficits in Executive Functioning Scale-Total EF Summary 
Score; R2 = .14; *p < .05 **p < .005 (Bonferroni-correctedp-value).
H ypothesis Five. Hypothesis Five states that cognitive functions at intake will be 
associated with treatment progression. To examine Hypothesis Five, a binary logistic 
regression analysis was performed to identify significant predictors o f  treatment 
progression, as measured by retention at follow-up testing point, among the measured 
executive cognitive functions at initial testing. The logistic regression model was not 
found to be significant, x2(10) = 14.45,/? = .153, and it explained 35.5% (Cox & Snell R2) 
o f  the variance in treatment retention while 72.7% o f cases were classified accurately. 
Results indicate that there were no significant predictors o f treatment retention at time o f 
follow-up testing among administered variables, including self-report EF problems, 
sustained attention, verbal fluency, working memory, planning ability, set-shifting ability, 
and response inhibition.
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Table 19. Logistic Regression Analysis Predicting Treatment Retention
Variable B SEB Wald P Odds
Ratio
Constant -8.26 29.49 .08 .779 .000
COWA .06 .06 .84 .359 1.06
LNS .41 .40 1.08 .300 1.51
GDS-1 3.22 4.03 .64 .423 25.14
GDS-2 -.02 .63 .001 .978 .983
GDS-3 -1.05 .60 3.31 .078 .35
SNST .02 .05 .17 .680 1.02
CTMT -.01 .06 .01 .927 .99
ToL-1 -.132 .09 2.30 .130 .88
ToL-2 .24 .32 .56 .454 1.27
BDEFS-T -.001 .01 .02 .895 .10
COWA = Controlled Oral Word Association; LNS = Letter-Number Sequencing 
Standard Score; GDS = Gordon Diagnostic System Delay ER; SNST = S troop 
Neuropsychological Screening Test; CTM T = Comprehensive Trail-Making Task 
Composite /-Score; GDS-2 = Vigilance Total Correct; GDS-3 = Vigilance Total 
Commissions; ToL-1 = Tower o f  London Task-Excess Moves; ToL-2 = Time to First 
Move; BDEFS-T = Barkley Deficits in Executive Functioning Scale-Total EF Summary 
Score; R2= .83; *p < .05 **p < .005 (Bonferroni-correctedp-value).
CHAPTER FOUR
DISCUSSION
The purpose o f the present study was to examine multiple elements o f executive 
functioning o f  individuals undergoing residential substance abuse treatment and to 
investigate the relationship between self-report EF problems and executive functioning 
variables, including sustained attention, verbal fluency, working memory, planning 
ability, set-shifting ability, and response inhibition. Further, this study investigated the 
performance o f  substance abusers on multiple measures o f  neurocognitive functioning 
when compared to established normative samples, as well as evaluating changes in 
functioning that occur during early abstinence while in treatment. In addition, the 
relationships between executive functioning and extent o f  substance abuse problems, 
identified personality problems, and treatment progression were evaluated. The project 
included 40 participants undergoing residential substance abuse treatment who were aged 
19 to 60 years. Gender differences were minimal, therefore results are reported for the 
combined sample. Only one significant difference was identified across 
neuropsychological measures, self-report EF scales, and measure o f problematic 
personality traits when comparing male and female subjects. Female participants reported 
significantly more difficulties with ability to organize thoughts and actions and create 
solutions to effectively problem solve compared to males.
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Several significant correlations were found among executive functioning 
measures at initial testing, ranging from .32 to .67, which is consistent with previous 
research. For example, working memory scores were found to be related to sustained 
attention and verbal fluency, whereas set-shifting ability was associated with sustained 
attention, impulsivity, response inhibition, and planning ability. One interesting finding 
was that verbal fluency (COWA) was related to only one other variable (the fewest o f 
any EF measure investigated) as it was positively correlated to LNS, a measure o f 
auditory working memory. One possible explanation for these results is that LNS and 
COWA are the only tests studied with exclusively verbal memory and recall skills 
utilized while all other measures possess some visual component as well. In addition, the 
observed correlations support the argument that identified executive functions are related, 
but dissociable, cognitive processes. These results also do not indicate that substance 
abuse greatly alters an individual’s general performance pattern across measures in 
relation to each other.
Further, the WASI full-scale IQ was not found to be significantly associated to 
any EF test utilized, although this may be related to the relatively low number o f 
participants who were administered this measure and the observed restriction in range o f 
scores (SD -  7.66). Further, planning ability, as measured by average time to first move 
on the ToL, was also not related to any other cognitive measure. This finding was 
inconsistent with previous research which has found an inverse correlation between 
problem errors and average first move time (Ward & Allport, 1997). Unexpectedly, 
number o f excessive moves was not related to amount o f planning time utilized before 
solving tasks.
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Relationship between Self-Report Ratings
and Neuropsychological Measures
Hypothesis One stated that self-report EF problems would be related to 
performance on EF tests at intake. However, the only EF test found to be related to any 
self-report scale was the number o f  correct responses on the GDS Vigilance scale which 
is a measure o f  sustained attention and impulsivity. Small to moderate negative 
correlations, -.26 to -.47, were found between number o f correct responses and BDEFS 
Total EF Summary score, self-management to time, self-organization, self-motivation, 
and emotional self-regulation. Although only one o f the Bonferroni-corrected correlation 
coefficients observed was significant, it is notable that the GDS Vigilance scale produced 
the greatest relationships across all BDEFS subscales and total score which suggests that 
mental vigilance and impulsivity was most closely related to identified problems with 
daily activities when compared to several EF tests. No other significant relationships 
were found between self-report EF scores (including BDEFS Total EF Summary score 
and five subscales) and performance on multiple neuropsychological measures (COWA, 
LNS, CTMT, SNST, and ToL). These findings were not completely consistent with 
previous research in which normative samples have exhibited significant associations, 
although small to moderate correlations, between subscales o f the BDEFS and similar EF 
measures, such as Conner’s Continuous Performance Task, WAIS-II1 Digit Span, Stroop 
Color-Word Interference Test, and Tower o f  London task (Barkley, 2011). It should be 
noted that absolute magnitudes o f many o f  the correlations found in this study between 
BDEFS subscales and EF measures were similar to significant correlation coefficients o f 
previous research which suggests that the present sample size may account for the lack o f 
significant findings.
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Although the BDEFS is measuring differing elements o f functioning (self­
management to time, self-organization/problem-solving, self-restraint, self-motivation, 
and self-regulation o f  emotions) it was expected that perceived functioning in these areas 
would be related to performance measures. The inconsistency between the present study 
and previous research may be related to the types o f samples utilized. Past research 
studies utilized normal and ADHD-diagnosed samples while the present investigation 
examined substance abusers. It may be that drug usage causes a unique pattern o f deficits 
affecting daily functioning and performance patterns on batteries o f neuropsychological 
testing in differing ways. Further, it may be that the relatively high level o f education (or 
general cognitive functioning) o f  the study sample limited the extent o f  deficits, in 
comparison to norm groups, while the BDEFS is better able to measure self-perceived 
reductions in functioning.
Interestingly, Barkley (2011) argues that EF rating scales, such as the BDEFS, are 
more predictive o f  problems in major life areas with higher ecological validity when 
compared to performance measures. This researcher suggests that results o f EF rating 
scales provide more clinically relevant information. It appears reasonable to argue that 
scores on rating scales may be more accurate measures o f  problems completing daily 
tasks due to EF deficits which can directing affect goal-directed behaviors and may be 
useful in the clinical evaluation o f  individuals with substance use disorders.
Overall Performance on Neuropsychological 
Measures
Hypothesis Two stated that participants would exhibit significant deficits on 
multiple neuropsychological measures at intake to substance abuse treatment. Participants 
did report significant deficits in EF and daily activities across four o f  five subscales o f  the
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BDEFS. They reported problems with time management, organization and problem­
solving, inhibition, and impulsivity. Subjects also endorsed problems with self- 
motivation and ability to maintain focus. Overall, 24 o f 40 participants reported EF 
deficits within the clinically significant or deficient ranges.
When compared to normative samples, participants exhibited significant deficits 
on only one o f  six EF tests administered. Moreover, only 8 o f  the 40 subjects exhibited 
deficits on more than 1 EF measure administered at intake. This is not consistent with 
previous research (Davis, Liddiard, & McMillan, 2002) which found a noticeably higher 
percentage o f  drug abusers exhibiting abnormal scores on at least two psychological 
measures. Similarly, Bates et al. (2002) explain that a majority o f alcohol-dependent 
individuals display neurocognitive impairments even during abstinence. Notably, the 
inconsistency o f  the study results with past research does not appear to be related to 
length o f abuse as the average periods o f  drug abuse were similar in the present study and 
the research o f  Davis et al. (2002).
Overall, study participants displayed reduced abilities in set-shifting, or cognitive 
flexibility, as measured by the CTMT. These results suggest impairment in the lateral 
frontal cortex and dorsolateral frontal cortex which are areas believed to be responsible 
for planning, abstract reasoning, and decision-making skills (Criaud & Boulinguez, 2013; 
Wilmsmeier et al., 2010). No significant problems were evident in sustained attention, 
impulsivity, or ability to maintain attention and manipulate information in working 
memory. Participants also did not exhibit deficits in verbal fluency or planning ability. 
These findings were not consistent with the stated hypothesis and previous research 
which has found deficits in substance users across multiple EF domains, including
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impulsivity, perseveration, decision-making, working memory, visual memory, planning 
ability, updating, flexibility, inhibition, and organizational skills (Dolan, et al., 2008; 
Ersche, et al., 2006; Parada et al., 2012; Pitel et al., 2007; Verdejo-Garcia et al., 2010).
One explanation for these unique findings may be the clientele o f  this addiction 
facility. Previous research (Tracy & Young, 2012) has found above average intellectual 
functioning among patients within this facility. It may be that any impairments in 
functioning due to substance abuse may be moderated by premorbid intellectual and 
cognitive abilities. The observed, generally normal functioning may in fact be evidence 
o f  reductions in functioning from higher levels. Premorbid cognitive functioning may 
also affect the level and severity o f usage thus impacting the overall amount o f 
impairment caused by substance abuse. Future research should more directly consider the 
relationship between global intellectual functioning and EF deficits associated with 
substance usage. Another possible explanation for these results may be that this higher 
functioning sample sought treatment at the behest o f  others, including social support 
systems and professional organizations, sooner after the development o f significant 
substance-related problems, and before more extensive cognitive damage occurred, 
compared to more typical substance-dependent samples.
It also should be noted that these findings may not suggest the absence o f 
extensive EF impairments in this sample because the self-report scores indicate 
significant problems within multiple areas. Although no single cognitive area appears to 
be grossly affected by substance abuse, it may be that smaller reductions in abilities 
across multiple domains result in impairments in behavioral functioning which are being 
self-reported. Further, researchers have found a self-report measure to be more sensitive
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than neuropsychological tests (including the Iowa Gambling Task and Stroop) in 
identifying EF problems and differentiating a substance use disorder group from a control 
group (Hagen et al., 2016). These results support the utility o f self-report measures in 
assessing neurocognitive functioning o f  individuals receiving substance abuse treatment. 
However, it is also possible that participants reported their EF problems experienced 
during substance usage and the results o f neuropsychological testing represent more 
current, and average, functioning.
Changes in Neuropsychological Performance 
during Abstinence
Hypothesis Three stated that participants would exhibit improvements in 
cognitive functioning after the cessation o f drug usage and a period o f abstinence within 
substance abuse treatment. Initially, investigators planned to use days o f abstinence prior 
to initial evaluation as a covariate within a series o f  ANCOVA procedures. However, 
number o f  clean days was not found to be associated with performance on administered 
measures. Thus a series o f  dependent samples /-tests were conducted in lieu o f 
ANCOVAs.
Results for this hypothesis indicated significant improvements for only three 
cognitive measures administered (SNST, CTMT, and ToL). Participants exhibited 
significantly better performances at follow-up on measures o f inhibitory control (SNST) 
and set-shifting abilities (CTMT) after approximately 45 days o f treatment. These 
findings are especially important when considering the cognitive processes likely critical 
in the decision-making process involved in stopping problematic substance usage and 
maintaining abstinence. Set-shifting, or cognitive flexibility, is necessary in both 
completing identified therapy tasks, such as twelve-step treatment program assignments,
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and appropriately shifting attention to more relevant stimuli or information, such as 
considering motivation or reasons to refrain from substance use, when performing cost- 
benefit analyses o f  usage. Deficits in cognitive flexibility can result in perseverance and 
difficulty effectively considering alternative behavioral options, such as when an 
individual experiences an urge to relapse. Cognitive flexibility is necessary in both taking 
various perspectives when problem-solving and in recognizing that a behavioral response 
utilized is ineffectual. Likewise, response inhibition involves the suppression o f 
automatic responses to stimuli, such as substance use due to physiological, psychological, 
or environmental cues. Moreover, problems with cognitive flexibility and response 
inhibition can negatively affect problem-solving which may lead to increased frustration, 
distress, and likelihood o f relapse to substance usage. Further, Blume and Marlatt (2009) 
suggest that the utilization o f more behavioral therapy techniques, as opposed to 
cognitive techniques, may be beneficial early in substance abuse treatment due to such 
deficits in EF.
Moreover, participants spent significantly less planning time, on average, before 
each initial move on trials o f  the ToL at follow-up testing. These results likely do not 
indicate reduced planning ability or deliberativeness, nor increased impulsivity during 
abstinence. Conversely, reduced planning time may indicate increasing levels o f 
effectiveness and efficiency in planning. As Berg and Byrd (2002) explain, initial 
planning time may be interpreted in two ways as it increases, either adaptive 
deliberativeness in planning or ineffective planning ability and difficulty in developing a 
course o f action. It appears likely that participants became more efficient in completing
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this task after several weeks o f  abstinence, and this suggests some level o f cognitive 
recovery and improvement in problem-solving skills.
In addition, these findings were not consistent with results o f other research which 
has found improvements within weeks o f  abstinence for substance abusers within the 
areas o f  working memory, information processing speed, and verbal fluency (Bates, 
Voelbel, Buckman, Labouvie, & Barry, 2005; Manning et al., 2008; Rapeli et al., 2006).
Overall, when considering possible explanations for the lack o f significant 
improvements at follow-up, it may be that few major changes were identified because 
initially participants exhibited significant deficits in only a limited number o f domains as 
performance in most cognitive areas fell within the average ranges. Interestingly, the 
sample also reported fewer EF problems overall and in the areas o f time management, 
self-organization, problem-solving, and impulsive behavior at follow-up testing.
Although the observed Bonferroni-corrected differences between initial and follow-up 
BDEFS and subscale scores were not significant, large effects sizes were found in each 
domain which suggests that a larger sample size may produce statistically significant 
results.
Predictors o f Personality Characteristics 
and Severity o f Substance Usage
Hypothesis Four stated that measures o f  EF would be predictive o f problematic 
personality characteristics, substance-related problems, and years o f substance usage. 
Three EF measures were found to be related to level o f substance-related problems, as 
measured by the SIP-D. Performance across multiple tests was not associated with scores 
on the AUDIT. Impulsivity and sustained attention, as measured by the Vigilance Task o f  
the GDS, and mental set-shifting were predictive o f level o f negative factors on the
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SIP-D, such as physical, social, intrapersonal, impulse control, and interpersonal 
problems associated with drug usage.
Interestingly, previous research has found that severity o f  drug usage and 
dependence are related to greater impairment in updating and set-shifting abilities, as 
well as increased perseverative errors, which was not observed in this study (Lyvers & 
Yakimoff, 2003; Verdejo-Garcia & Perez-Garcia, 2007). Although this sample exhibited 
deficits in set-shifting ability (CTM T scores), these scores were not associated with drug 
use severity/problems. Further, self-report EF deficits were predictive o f SIP-D scores 
but not AUDIT scores. Problems in areas such as time management, emotional 
regulation, self-restraint, and level o f  effort were predictive o f drug-related problems 
across multiple domains. These findings may be explained by the fact that the SIP-D 
items are more similar to BDEFS items than the AUDIT in that questions are assessing 
impulse control and interpersonal problems while AUDIT questions are primarily 
focused on usage patterns.
Years o f  substance usage, as measured by self-report years o f  abuse o f  drug o f 
choice, was also unrelated to self-report EF problems or neuropsychological performance 
on EF measures. Previous research in this area has shown varying results. Loeber et al. 
(2009) found increased problems with working memory and attention were associated 
with more years o f  alcohol dependence. However, other researchers have found years o f 
usage for opiates and amphetamines was not related to severity o f  EF impairment (Ersche 
et al., 2006). One could conclude that type o f substance may mediate the relationship 
between length o f  usage and level o f  cognitive impairment and types o f  deficits observed.
93
Likewise no EF tests were associated with level o f  problematic personality 
problems. These results were not expected as personality problems are commonly 
observed in substance abusing samples as these individuals are four times more likely to 
be diagnosed with a personality disorder than healthy controls (Armstrong & Costello, 
2002). Further, previous research examining the comorbidity o f  personality disorders and 
substance abuse has estimated that approximately 19% o f individuals with at least one 
personality disorder will experience drug dependence and 42% will experience lifetime 
alcohol dependence, with rates even higher for certain disorders such as antisocial 
personality disorder and borderline personality disorder (Trull, Jahng, Tomko, Wood, & 
Sher, 2010). Moreover, neuroticism, obsessive compulsive personality traits, and 
borderline personality disorder have been found to be associated with EF deficits, 
including problems in planning, fluency, sustained attention, and working memory 
(Garci'a-Villamisar & Dattilo, 2015; Gvirts et al., 2012; Schretlen et al., 2010).
The regression model conducted isolated only one significant predictor o f 
perceived personality problems. Findings indicated that a higher level o f  self-report EF 
deficits was related to more identified problematic personality traits, and these results 
provide support for previous research which has found personality disorders to be related 
to EF problems. These findings were expected as several EF deficits measured, such as 
impulsivity, lack o f  motivation/effort, reduced self-restraint, and irregulated emotions, 
appear closely related to multiple characteristics o f  personality disorders, such as 
emotional instability, impulsive/reckless behaviors, irritability, consistent irresponsibility, 
and instability in goals. Overall, these results again may be related to the generally 
average performance o f  the sample on the neuropsychological tests administered.
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Predictors o f Treatment Retention
Hypothesis Five stated that neuropsychological measures would be predictive o f  
treatment retention at testing follow-up (approximately 45 days after initial testing). 
Previous research has found reduced treatment retention to be significantly related to EF 
deficits. Verdejo-Garcia et al. (2012) found lower scores on an EF measure o f one’s 
ability to multitask and organize sub-goals predictive o f fewer days in treatment. Further, 
performance on the Stroop Color-Word Interference Test, inhibitory control, 
perseverative errors, attention, mental speed, and spatial ability have been found to 
significantly predict treatment completion among samples o f  individuals receiving 
outpatient substance abuse treatment (Aharonovich et al., 2006; Streeter et al., 2008).
Results o f this study found no neuropsychological measures predictive o f 
treatment retention. Moreover, self-report EF problems also were not associated with 
treatment retention. One explanation o f  these findings may be the overall 
neuropsychological performance o f  the sample. As previously described, participants 
within this study did not exhibit the level o f  deficits frequently observed in studies o f 
neuropsychological performance o f  substance abusers. The fact that the current study 
examines residential treatment (as opposed to outpatient treatment assessed in similar 
research) and includes 25% o f participants receiving treatment in order to maintain their 
current work status, may also have impacted study findings related to treatment retention. 
Study Strengths and Limitations
This section will consider possible strengths and limitations o f the present study 
and potentially impactful future research directions. One strength o f  this study was the 
extensive neuropsychological battery utilized which assessed a variety o f  executive
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functions critical to daily functioning, including set-shifting, working memory, response 
inhibition, sustained attention, impulsivity, verbal fluency, and planning ability. Notably, 
when examining the pattern o f performance in relation to the test administration order, 
there was no indication o f response fatigue. Further, the inclusion o f a self-report EF 
rating scale is uncommon in similar research studies. The utilization o f a residential 
program treating a relatively unique clientele could be considered to be both a strength 
and weakness o f  this study. Since this sample is likely to be noticeably different from 
many similar studies which utilize community and government-related addiction 
treatment facilities, findings may aid in the development o f  treatment plans for similar 
clients seeking treatment. However, given the ethnic composition, level o f education, and 
career backgrounds o f the participants, findings should be cautiously generalized when 
considering other groups o f substance-abusing individuals. The present research project 
also possesses multiple limitations which may have impacted the results and 
interpretative conclusions. Firstly, the participant pool was comprised o f  nearly all 
Caucasians (95%) which greatly differs from the current U.S. population. Further, 
subjects were recruited from only one private treatment facility within the Southern U.S. 
which limits the availability o f  potential participants eligible for this study. The sample 
also consisted o f 60% college graduates and 87.5% o f individuals had at least some 
college experience while participants who were administered the WASI exhibited a mean 
FSIQ o f 106. These characteristics are noticeably different from national statistics 
because approximately 36.2% o f adults between 25 and 64 years o f age have earned a 
degree beyond secondary education (United States Department o f Education National 
Center for Education Statistics, 2015).
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Further, due to the clientele o f  the private addiction treatment facility utilized, at 
least 25% o f the sample were professionals, such as medical and legal professionals, 
referred to treatment in order to maintain their employment status. Increased ethnic and 
socioeconomic diversity and investigation in various types o f treatment facilities would 
likely improve future research examining deficits in executive cognitive functioning and 
its association to treatment response for substance abusing individuals.
In addition, likely the most problematic limitation o f the study was the overall 
sample size o f 40 participants, with 21 o f those being retested at follow-up. Due to 
multiple issues recruiting subjects, the number o f participants assessed was reduced after 
testing began. The final number o f  participants included may have reduced the power o f 
the study to detect significant findings, and researchers’ capacity to identify 
neurocognitive deficits and improvement may have been affected. The number o f 
participants studied also limited researchers’ ability to consider any potential differences 
in performance based on individuals’ substance o f  choice. Moreover, study results may 
have been affected by the fact that certain variables were based on self-report measures, 
and even though participants were directly informed that results would not be shared with 
facility staff or affect treatment status, responses may have been influenced by the 
treatment setting.
An additional limitation to the study was the inability to assess the reason for 
early treatment cessation for many participants. This data may have helped to elucidate 
the impact o f neuropsychological functioning on treatment response. Future research 
should attempt to follow-up with participants in order to better understand what, if  any, 
relationship that may exist between EF and treatment completion/response.
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Future Research
Ongoing research investigating neuropsychological deficits related to substance 
abuse should continue to examine more unique samples such as this study which included 
individuals with generally higher levels o f  education and intellectual ability. Further, 
research should continue to explore how neurocognitive functioning is related to, and 
influences an individual’s response to treatment and recovery process. Research may 
benefit from including clinician ratings o f  patients’ treatment participation and progress. 
Investigating how performance on neuropsychological measures are related to observer 
ratings may help to better understand how EF deficits impact recovery from substance 
use disorders and ongoing abstinence.
Additional research considering the utility o f  self-report measures o f  functioning 
may also be vital. If  more fully shown to be valid assessments o f  functioning for 
individuals with substance use disorders, then self-report measures may be a less 
expensive, less time consuming, and more efficient means o f identifying individuals with 
severe cognitive deficits which could impact treatment planning and response. This is 
especially important when considering the influence o f  insurance and managed health 
care companies on the access to, and duration/type of, treatment available to many 
individuals.
Further, a comparison o f participants’ neuropsychological functioning and 
response to treatment based on drug o f  choice may be especially beneficial in further 
understanding and effectively treating substance use disorders. Previous research has 
considered differences in cognitive performance across certain drugs o f choice (Ersche et 
al., 2006; Sclafani et al., 2002). However, minimal research has attempted to examine
how EF patterns change during abstinence and how this may impact treatment success. 
Increased usage o f  longitudinal studies appears necessary in order to more fully 
investigate EF predictors o f  treatment response and effective treatment interventions for 
individuals identified with EF deficits. O f particular utility may be longitudinal studies 
examining premorbid cognitive and executive functioning in order to better understand 
the neurocognitive effects o f substance usage and subsequent cognitive recovery during 
abstinence.
APPENDIX A 
HUMAN SUBJECTS CONSENT FORMS
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HUMAN SUBJECTS CONSENT FORM
The following is a brief summary o f the project in which you are asked to 
participate. Please read this information before signing the statement below._______
TITLE OF PROJECT: Examining the Relationship between Executive Functioning and 
Substance Abuse -Part 1.
PURPOSE OF STUDY/PROJECT: The purpose o f  the present study is to examine the 
relationship between executive functioning and substance abuse. Further, the association 
between executive functioning and response to substance abuse treatment will be 
investigated.
PROCEDURE: Prior to participation, you must sign an informed consent. By providing 
your informed consent, you will be granting the researchers access to the results from 
certain questionnaires and tests administered by Palmetto Addiction Recovery ('enter 
(PARC) staff.
INSTRUMENTS: The only measures which the researchers will have access to are the 
Brief Assessment o f Traits-37, Comprehensive Trail-Making Task, Stroop 
Neuropsychological Screening Test, and Wechsler Abbreviated Scale o f  Intelligence.
RISKS/ALTERNATIVE TREATMENTS: The participant understands that Louisiana 
Tech is not able to offer financial compensation nor to absorb the costs o f medical 
treatment should you be injured as a result o f participating in this research.
BENEFITS/COMPENSATION: You will not be compensated for participating in this 
study.
I , _____________________ , attest with my signature that I have read and understood
the following description o f the study. "Examining the Relationship between 
Executive Functioning and Substance Abuse," and its purposes and methods. I 
understand that my participation in this research is strictly voluntary and mv 
participation or refusal to participate in this study will not affect my relationship 
with Palmetto Addiction Recovery Center in any wav. Further, I understand that I 
may withdraw at any time or refuse to answer any questions without penalty. Upon 
completion o f the study, I understand that the results will be freely available to me 
upon request. I understand that the results o f my measures will be confidential, 
accessible only to the principal investigators, myself, or a legally appointed 
representative. I have not been requested to waive nor do I waive any o f my rights 
related to participating in this study.
Signature o f Participant or Guardian Date
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CONTACT INFORMATION: The principal experimenters listed below may be 
reached to answer questions about the research, subjects' rights, or 
related matters.
PROJECT DIRECTOR(S): John Tracy, M.A., and Tony Young, Ph.D.
PHONE: 318-257-5066; 318-257-2449
Members of the Human Use Committee o f Louisiana Tech University may also be 
contacted if  a problem cannot be discussed with the experimenters: Dr. Stan Napper 
(257-3056) or Dr. Mary M. Livingston (257-2292 or 257-5066)
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HUMAN SUBJECTS CONSENT FORM
The following is a brief summary o f the project in which you are asked to 
participate. Please read this information before signing the statement below._______
TITLE OF PROJECT Examining the Relationship between Executive Functioning and 
Substance Abuse-Part 2.
PURPOSE OF STUDY/PROJECT: The purpose o f the present study is to examine the 
relationship between executive functioning and substance abuse. Further, the association 
between executive functioning and response to substance abuse treatment will be 
investigated.
PROCEDURE: Prior to participation, you must sign an informed consent. After your 
consent form is signed, you will be asked to complete a questionnaire which will take 
about 15 minutes. You also will be asked to complete four neuropsychological tasks 
which will take about 40 minutes. Please answer the questions truthfully and to the best 
o f your ability. In approximately two months, you will be asked to complete part o f  the 
initial questionnaire and complete the same neuropsychological tasks again which will 
take about 70 minutes. During the fourth and eighth weeks o f  treatment, your primary 
counselor will be asked to complete a questionnaire concerning your progress and 
engagement in treatment.
INSTRUMENTS: The questionnaires contain multiple surveys which include questions 
about your background and history, substance-related problems, and cognitive problems 
such as poor attention or memory. The neuropsychological tasks will primarily measure 
your executive functions, such as working memory, attention, and planning ability. The 
Clinician Patient Rating Scale completed by your counselor will measure your 
participation and progress in treatment.
RISKS/ALTERNATIVE TREATMENTS: The participant understands that Louisiana 
Tech is not able to offer financial compensation nor to absorb the costs o f medical 
treatment should you be injured as a result o f participating in this research.
BENEFITS/COMPENSATION: You will not be compensated for participating in this 
study.
Before providing your informed consent and signing below please check the 
following boxes indicating that you understand the procedures o f this study.
□
I understand that 1 will be administered additional measures that are not part o f  the 
standard assessment battery o f PARC.
□
I understand that I am giving the researcher permission to contact my primary counselor 
concerning my treatment progress.
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I , _____________________ , attest with my signature that I have read and understood
the following description o f the study, "Examining the Relationship between 
Executive Functioning and Substance Abuse," and its purposes and methods. I 
understand that my participation in this research is strictly voluntary and mv 
participation or refusal to participate in this study will not affect mv relationship 
with Palmetto Addiction Recovery Center in any wav. Further, I understand that I 
may withdraw at any time or refuse to answer any questions without penalty. Upon 
completion o f the study, I understand that the results will be freely available to me 
upon request. I understand that the results o f my measures will be confidential, 
accessible only to the principal investigators, myself, or a legally appointed 
representative. I have not been requested to waive nor do I waive any o f my rights 
related to participating in this study.
Signature o f Participant or Guardian Date
CONTACT INFORMATION: The principal experimenters listed below may be 
reached to answer questions about the research, subjects' rights, or related matters.
John Tracy, M.A., Tony Young, Ph.D. PHONE: 318-257-5066; 318-257-2449
Members o f the Human Use Committee o f Louisiana Tech University may also be 
contacted if  a problem cannot be discussed with the experimenters:






Please do not put your name or any other identifying information on any o f the 
provided survey materials. Please answer all questions as truthfully as possible. 
Circle the answer which best describes you.
Directionst Please answer the following questions by filling in the blank or circling 
the npprniiHitta aitswer
A g e:_________________  Sex: 1. Male 2. Female
With which ethnic group do you most identify?
1. African-American 2. Asian-American 3. Caucasian
4. Hispanic/Latin 5. Native American 6. Other:______________________
Spirituality:
1. Not at all spiritual 2. Not very spiritual 3. Somewhat spiritual 4. Very spiritual
Church Involvement:
1. Very involved (attend church events more than once a week)
2. Involved (attend at least once a week)
3. Slight involvement (attend church events occasionally)
4. No involvement
Religious Persuasion:
1. Atheist (do not believe in God) 2. Unsure o f  religious beliefs 3. Religious
Parental status during majority o f  childhood:
1. Two parents
2. Single parent
3. Extended family (grandparent, aunt, other)
4. Parents and extended family
5. Adopted parents
Highest level o f  education completed:
1. Elementary 2. Middle School 3. High School Diploma or GED
4. Some college experience 5. College Degree
Why are you entering into this program?
1. You are tired o f your current situation and believe you need help to change things
2. Your family has pressured you into participating in some type o f treatment
3. You have been ordered to participate by a court, lawyer, OCS, or government agency






1 Alcohol -  Any use at all











How many days since your last substance (alcohol/drug usage)?______________________
Which substance is the major problem/drug o f cho ice?______________________________
Please code as above or 00-N o  Problem.
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